JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2006) 188, 135-153       DOI: 10.1677/joe.1.06595
© 2006 Society for Endocrinology
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balla, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balla, T

REVIEW

Phosphoinositide-derived messengers in endocrine signaling

T Balla

Endocrinology and Reproduction Research Branch, NICHD, National Institutes of Health, Building 49, Room 6A35, 49 Convent Drive, Bethesda, Maryland 20892, USA

(Requests for offprints should be addressed to T Balla; Email: ballat{at}mail.nih.gov)


    Abstract
 Top
 Abstract
 Introduction
 Receptor-mediated InsP3...
 Cell-surface receptors and PI3K...
 Phosphoinositides and ion...
 Phosphoinositides and exocytosis
 Cellular lipid homeostasis and...
 Nuclear receptors, nuclear...
 Concluding remarks
 References
 
One of the fundamental questions in endocrinology is how circulating or locally produced hormones affect target cell functions by activating specific receptors linked to numerous signal-transduction pathways. An important subset of G protein-coupled cell-surface receptors can activate phospholipase C enzymes to hydrolyze a small but critically important class of phospholipids, the phosphoinositides. Although this signaling pathway has been extensively explored over the last 20 years, this has proven to be only the tip of the iceberg, and the multiplicity and diversity of the cellular functions controlled by phosphoinositides have surpassed any imagination. Phosphoinositides have been found to be key regulators of ion channels and transporters, and controllers of vesicular trafficking and the transport of lipids between intracellular membranes. Essentially, they organize the recruitment and regulation of signaling protein complexes in specific membrane compartments. While many of these processes have been classically studied by cell biologists, molecular endocrinology cannot ignore these recent advances, and now needs to integrate the cell biologist’s views in the modern concept of how hormones affect cell functions and how derailment of simple molecular events can lead to complex endocrine and metabolic disorders.


    Introduction
 Top
 Abstract
 Introduction
 Receptor-mediated InsP3...
 Cell-surface receptors and PI3K...
 Phosphoinositides and ion...
 Phosphoinositides and exocytosis
 Cellular lipid homeostasis and...
 Nuclear receptors, nuclear...
 Concluding remarks
 References
 
The mechanism of action of ‘Ca2+-mobilizing hormones’, a term introduced in the mid-1970s to denote hormones that exert their effects through generation of a cytosolic Ca2+ signal, was largely elucidated by the end of the 1980s (Fig. 1Go and 2Go). The basic elements of this canonical signal-transduction cascade include the activation of the phospholipase C (PLC) ß and {gamma} isoforms by G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs) respectively. Stimulation of these receptors generates two second messengers, the soluble Ins(1,4,5)P3 (InsP3) and the hydrophobic diacylglycerol from membrane, PtdIns(4,5)P2 (Berridge 1984). Once generated, the Ca2+-mobilizing messenger, InsP3, binds to specific receptors that are located mainly in the endoplasmic reticulum (ER) and function as tetrameric cation channels to release Ca2+ from intracellular Ca2+ stores (Mikoshiba 1997). This endogenous Ca2+ signal, in combination with increased Ca2+ influx via multiple Ca2+ entry mechanisms, activates numerous cytoplasmic and membrane-bound effector molecules with the help of Ca2+-binding proteins. Ca2+ is also taken up by mitochondria, where it stimulates metabolic enzymes (Hajnoczky et al. 1995) or initiates complex responses such as apoptosis (Pacher & Hajnoczky 2001). The other limb of this messenger system, diacylglycerol (DAG), directly activates several members of the protein kinase C family (Nishizuka 1988), and can also contribute to the direct regulation of some ion channels (Hardie 2003).


Figure 1
View larger version (37K):
[in this window]
[in a new window]
 
Figure 1 Updated version of the classical ‘PI cycle’. Plasma membrane PtdIns(4,5)P2 is hydrolyzed by PLC enzymes, after receptor stimulation, to generate two second messengers, Ins(1,4,5)P3 and DAG. Ins(1,4,5)P3, which mobilizes intracellular Ca2+, is rapidly degraded by sequential dephosphorylations to yield myo-inositol. (A fraction of the Ins(1,4,5)P3 is converted to higher inositol phosphates via pathways that differ between plants, yeast and vertebrates (Shears 2004), but it is not shown in the figure for better clarity.) Some of the dephosphorylating enzymes on the pathway of Ins(1,4,5)P3 degradation are sensitive to inhibition by Li+ ions, a finding that led to the idea that the therapeutic effects of Li+ in bipolar disorder might be related to altered signaling affecting primarily hyperactive receptors (Berridge et al. 1989). DAG, the other product of PtdnIns(4,5)P2 hydrolysis, activates PKC enzymes (and some other effectors, such as ion channels or protein kinase D (PKD) – not shown) before being converted to PtdA by DAG-kinase enzymes. PtdA of the plasma membrane can also activate certain effectors (not shown). In the endoplasmic reticulum (ER), PtdA is converted to CDP-DAG, which is conjugated with myo-inositol by PI synthase enzyme(s). When cells are stimulated in the presence of Li+, CDP-DAG accumulates because of the shortage of myo-inositol derived from phosphoinositide hydrolysis. The PtdIns of the ER is transferred to the plasma membrane by PI transfer proteins, but it is less clear whether a similar mechanism transfers PtdA between the membranes. Most downstream pathways in this messenger system are regulated by PKC and other Ca2+-responsive protein kinases or phosphatases.

 

Figure 2
View larger version (39K):
[in this window]
[in a new window]
 
Figure 2 G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs) activate PtdIns(4,5)P2 hydrolysis by distinct mechanisms, the former using G protein-mediated activation of PLCß isoforms, and the latter causing PLC{gamma} activation. Ins(1,4,5)P3 binds to its receptors located primarily in the ER in the form of tetrameric Ca2+ channels releasing Ca2+ from the internal stores. The N-terminal Ins(1,4,5)P3-binding domain of the InsP3 receptor is probably in close proximity to the C-terminal channel domain with a long intervening regulatory domain (see insert). Emptying of the ER Ca2+ pools relays information (by unknown mechanisms) to plasma membrane Ca2+ channels, commonly termed store-operated Ca2+ channels (SOC), to enhance Ca2+ influx into the cell. Members of the TRP family of Ca2+ channels may function as SOC, and it has been suggested that there is a physical regulatory contact between plasma membrane-adjacent InsP3 receptors and certain TRP channels (see text for details). Another spatial organization is related to the ‘coupling’ of Ca2+ release via the InsP3 receptors with uptake by mitochondria that are juxtaposed to InsP3 receptor-rich ER domains.

 
This elegantly simple concept marked only the beginning of an amazing explosion of research into phosphoinositides, and almost every component of the calcium-phosphoinositide messenger system has grown to become a research field of its own. The metabolism of InsP3 via both phosphorylation and sequential dephosphorylation revealed the identity of several inositol phosphate isomers (Shears 1998), as well as the InsP kinases (Verbsky et al. 2005) and phosphatases (Majerus et al. 1999). We are just at the beginning of understanding which of the numerous inositol phosphate isomers have regulatory functions. The discovery of phosphoinositide 3-kinases (PI3K) was the starting point in the recognition of the function of phosphoinositides as membrane-bound signaling molecules and was one of the main driving forces behind the search for proteins that are downstream targets of the inositol phospholipids. With the identification of new forms of inositol lipids and newly discovered functions of their classical forms, came the cloning of the multiple forms of inositide lipid kinases (Fruman et al. 1998) and phosphatases (Majerus et al. 1999), several of which have also been linked to human diseases (Pendaries et al. 2003) (Fig. 3Go). Research into the calcium aspect of InsP3- mediated signaling has also shown an enormous expansion, starting with the cloning of the InsP3 receptor (Furuichi et al. 1989, Mignery et al. 1989) and the continuing quest to identify the molecular entities behind the store-operated Ca2+ entry (SOC) pathway (Parekh & Putney 2005). There are several excellent reviews covering almost every aspect of inositide research from the viewpoint of the protein classes as indicated above. This review cannot be a compilation of all of these areas. Instead, it will aim to summarize recent advances and open questions from selected areas of endocrine research pointing to the inositol lipid angle within those areas. This is a selection with an inevitable bias and is by no means an indication that other aspects of inositides are not important in endocrinology. After all, it could be claimed that there are only two kinds of research: one in which phosphoinositides are already implicated and another where their involvement is yet to be recognized!


Figure 3
View larger version (35K):
[in this window]
[in a new window]
 
Figure 3 The network of interconversions between phosphoinositides. Phosphoinositides are phosphorylated (red arrows) by inositide kinases and are dephosphorylated (blue arrows) by phosphoinositide phosphatases. Most (but not all) of the kinases are quite specific and phosphorylate only one substrate in a specific position on the inositol ring. Some kinases (such as the class II PI 3-kinases, PI3KC2) show wider substrate tolerance in vitro but are likely to have a clear substrate preference in vivo. The substrate specificity of most (but not all) phosphatases is less stringent in vitro, and some can dephosphorylate lipids as well as the soluble inositol phosphates. The physiologic and preferred substrate is not known for all inositide phosphatases, nor is it known in all cases which enzyme or enzymes are primarily responsible for a specific interconversion step. For example, Sac1 phosphatases can remove the 3- and 4-phosphates from a mono-phosphorylated inositol lipid, but synaptojanins (Snj), which are primarily known as 5-phosphatases, also contain a Sac1 phosphatase motif and can function as Sac1 phosphatases (Guo et al. 1999). Since myotubularin-related inositol lipid phosphatases (MTMRs) (Taylor & Dixon 2003) also dephosphorylate the 3 position on PtdIns(3)P, it is likely that PtdIns(3)P is dephosphorylated by Sac1, Snj-s and MTMRs in different cellular compartments (Parrish et al. 2004). This figure indicates only the more established routes; for all other possibilities of interconversion, see Abel et al.(2001).

 

    Receptor-mediated InsP3 formation and Ca2+ release
 Top
 Abstract
 Introduction
 Receptor-mediated InsP3...
 Cell-surface receptors and PI3K...
 Phosphoinositides and ion...
 Phosphoinositides and exocytosis
 Cellular lipid homeostasis and...
 Nuclear receptors, nuclear...
 Concluding remarks
 References
 
When Ca2+-mobilizing receptors engage their agonist ligands, the subsequent activation of PLC enzymes at the plasma membrane leads to rapid breakdown of PtdIns(4,5)P2. This process is both amplified and at the same time self-limited in a number of ways. It is amplified because of the positive regulation of PLC enzymes by cytoplasmic Ca2+, an effect that accounts for the profound impact of Ca2+ release on the extent of PtdIns(4,5)P2 hydrolysis (e.g. Horowitz et al. 2005). Without receptor activation, Ca2+ per se is much less potent, and only large cytoplasmic Ca2+ increases lead to PtdIns(4,5)P2 breakdown. Although all PLC enzymes are Ca2+-sensitive, the PLC{delta}1 enzyme appears to be largely responsible for Ca2+-mediated positive feedback on InsP3 generation (Rhee 2001). At the same time, the process of InsP3 formation is limited because most GPCRs undergo homologous desensitization that limits their ability to activate G-proteins (Luttrell & Lefkowitz 2002). Moreover, both GPCRs and RTKs undergo ligand-induced endocytosis and are rapidly removed from the plasma membrane, whence they can also be quickly recycled and reappear during resensitization (Gaborik & Hunyady 2004). PtdIns(4,5)P2 hydrolysis is also limited because, as a result of its relatively low level in the membrane, it has to be replenished by the sequential actions of PI 4- and PIP 5-kinases on the larger pools of PtdIns. Even the larger pool of plasma membrane PtdIns can become depleted if not maintained by supply from the ER by PI transfer proteins (Fig. 1Go).

Which inositol lipid pools participate in the classical signaling cascade and which enzymes are primarily responsible for their generation?

The existence of hormone-sensitive and insensitive pools of phosphoinositides has been described in early research using metabolic labeling with myo-inositol (Koreh & Monaco 1986). Recent studies have indicated that PtdIns(4,5)P2 is produced by two different pathways: in the canonical pathway, it is formed through PtdIns(4)P by sequential phosphorylations by PI 4-kinases (Balla 1998) and the type I PIP kinases (or PIP5Ks) (Hinchliffe et al. 1998). In a recently recognized pathway, PtdIns(4,5)P2 synthesis proceeds via PtdIns(5)P that is phosphorylated by type-II PIP kinases (or PIP4Ks) (Rameh et al. 1997) (Fig. 3Go). Since each group of enzymes has multiple forms that are located in distinct cellular compartments, it is inevitable that phosphoinositides will be generated in different types of membranes. Which of these inositide pools are linked to hormone action? It is widely assumed that hormonal stimulation leads to breakdown of the plasma membrane PtdIns(4,5)P2 pool, and this has been substantiated by the use of green fluorescent protein (GFP)-fused pleckstrin homology (PH) domains that recognize the lipid in the plasma membrane. However, PtdIns(4,5)P2 pools also exist in other membrane locations, such as the Golgi, the ER and the nucleus (Watt et al. 2002), and PLC enzymes are also found at these sites (Rebecchi & Pentyala 2000). Therefore, it is not unreasonable to assume that PLC activation – either direct, or mediated by the cytoplasmic Ca2+ increase – occurs at intracellular membranes and contributes to InsP3 and DAG generation at those sites with local consequences.

Equally important is the simple question of whichenzymes generate the PI(4,5)P2 that is subject to receptor-controlled PLC-mediated hydrolysis. Recently, it was shown that human PIP 5-kinase {gamma} is the enzyme that is necessary for GPCR-mediated InsP3 formation and Ca2+ signaling (Wang et al. 2004). In contrast, mouse PIP 5-kinase Iß (identical to human PIP5KI{alpha}), recruited by Bruton’s tyrosine kinase, enhances Ca2+ signaling in B cells (Saito et al. 2003). Stimulation of PIP 5-kinase activity by small guanosine triphosphate (GTP)-binding proteins has been well documented (Chong et al. 1994, Honda et al. 1999), but it is not known whether receptor-mediated activation of PIP 5-kinase activity occurs. A very rapid increase in PtdIns(4,5)P2 level after stimulation has been recently demonstrated, suggesting direct activation of PtdIns(4,5)P2 synthesis (Xu et al. 2003). Less clear is the identity of the PI 4-kinase or kinases that provide PtdIns(4)P for the PIPKs. Hormone-sensitive PtdIns(4)P pools have been shown to be generated by the type-III PI4Ks (which are sensitive to higher concentrations of PI3K inhibitors) (Nakanishi et al. 1995). However, neither the PI4 KIII{alpha} nor -ß isoform is detectable at the plasma membrane of mammalian cells; instead, these isoforms are located in ER and Golgi membranes respectively (Wong et al. 1997). Yet, recent studies have shown that a plasma membrane (PM) pool of PtdIns(4)P is generated by PI4 KIII{alpha} (Balla et al. 2005), raising the question of whether the lipid is generated at the PM by a small fraction of the enzyme or is generated elsewhere and transported to the PM. There is little direct evidence that PI4K activities are stimulated during receptor activation, and only PI4 KIIß has been shown to be activated by a Rac-dependent mechanism (Wei et al. 2002).

As mentioned above, the maintenance of PtdIns(4,5)P2 pools also requires the function(s) of the family of PI transfer proteins (PITPs). These proteins transfer PtdIns and PtdCho between membranes and are necessary for maintenance of the PLC-sensitive phosphoinositide pools (Thomas et al. 1993). PITPs also exist in several forms, of which the soluble PITP{alpha} and PITPß isoforms have non-overlapping functions that reach far beyond the regulation of hormone-sensitive phosphoinositide pools, affecting both phospholipid synthesis and vesicular trafficking. This function of lipid-transfer proteins will be further detailed below.

How does InsP3 regulate Ca2+ release?

Since the isolation and cloning of the InsP3 receptor channels, impressive progress has been made in understanding their functions. All three isoforms of the InsP3 receptor (types I, II and III) function as intracellular Ca2+ channels that operate as a homo- or heterotetramer (Mikoshiba 1993). Each receptor subunit has a channel portion containing six transmembrane helices and a pore domain located between TM5 and TM6, close to the C-terminus of the protein (Maeda et al. 1991, Galvan et al. 1999, Patel et al. 1999). The ligand-binding domain (LBD) of the receptor is located at the N-terminus (Mignery & Sudhof 1990) and is separated from the channel domain by a long intervening regulatory region facing the cytoplasm (Mignery & Sudhof 1990, Mikoshiba 1993). InsP3 binding leads to rapid activation of the channel, but Ca2+-induced Ca2+ release, similar to that featured in the related ryanodine receptors (RyR), is also an important regulatory mechanism of IP3Rs (Taylor & Laude 2002). Because of their ER location, little is known about the gating mechanism and properties of IP3R channels. The only electrophysiologic data are derived from isolated channels reconstituted in lipid bilayers (Bezprozvanny et al. 1991) or from patch-clamp recordings of the nuclear envelope (Mak & Foskett 1994). Most of our knowledge of the behavior of the intact channels is inferred from measurements of Ca2+ (or other cation) fluxes. These studies have provided invaluable information about the InsP3 and Ca2+ regulation of the channel (Bezprozvanny et al. 1991, Hajnoczky & Thomas 1994), but no molecular mechanisms or states have been correlated with channel behavior. One major question is how the N-terminal LBD can regulate the channel itself. Recent evidence suggests that the C-terminal channel domain and the N-terminal LBD are in very close molecular proximity, and that the ligand-induced conformational change within the LBD could be transferred to the channel domain itself (Boehning & Joseph 2000). The recently solved X-ray structure of the LBD (Bosanac et al. 2002) and the adjacent N-terminal inhibitory domain (Bosanac et al. 2005) has helped to clarify the structural basis of InsP3 binding, and, together with high-resolution electron microscopy and 3-D reconstruction of the channel structure (Jiang et al. 2002, da Fonseca et al. 2003, Sato et al. 2004), should advance our understanding of the gating mechanism of the protein.

The positioning of ER membranes containing InsP3 receptors relative to other membranes, and the interaction of the receptor with other proteins, add to the complexity of Ca2+ regulation in local compartments (Fig. 2Go). Early fractionation studies suggested that InsP3 receptors could be isolated from ‘mitochondrial’ (Dawson & Irvine 1984) and ‘plasma membrane’ (Guillemette et al. 1988) fractions, indicating ER contamination of these fractions enriched in InsP3 receptors. Recent evidence has shown the existence of a special ER–mitochondria interface (Rizzuto et al. 1993) and a very close ‘quasi-synaptic’ functional coupling between InsP3 receptor-mediated Ca2+ release and mitochondrial Ca2+ uptake (Csordas et al. 1999). Moreover, the physical association of InsP3 receptors with TRPC3 channels at the plasma membrane could provide the basis for Ca2+ influx regulation linked to InsP3-induced Ca2+ release (Kiselyov et al. 1998). These observations raise the question of whether the InsP3R could serve as a structural participant in the tethering of the ER to other membranes in the proximity of the channel. It has also been suggested that the LBD of the InsP3R binds to PtdIns(4,5)P2 of the plasma membrane in quiescent cells when InsP3 levels arelow (Glouchankova et al. 2000), and that changing PtdIn(4,5)P2 together with increased InsP3 could also participate in the regulation of these channels.


    Cell-surface receptors and PI3K-mediated signaling
 Top
 Abstract
 Introduction
 Receptor-mediated InsP3...
 Cell-surface receptors and PI3K...
 Phosphoinositides and ion...
 Phosphoinositides and exocytosis
 Cellular lipid homeostasis and...
 Nuclear receptors, nuclear...
 Concluding remarks
 References
 
The classical activation mechanism of PI3Ks was identified by studies on receptor tyrosine kinases and on soluble and oncogenic tyrosine kinases (Otsu et al. 1991). In these systems, the p85 regulatory subunit associates with tyrosine-phosphorylated target sequences through its SH2 domains, recruiting the cytoplasmic PI3K{alpha} or -ß catalytic subunit to the membrane. The p85 subunit becomes tyrosine phosphorylated during this process, leading to increased activity of the kinase. Less is known about the mechanism of PI3K activation in the case of GPCRs. In hematopoietic cells, where PI3K{gamma} is found in significant amounts, activation via the ß{gamma}-subunits of Gi/Go proteins is the main activation pathway (Stephens et al. 1994). This is mediated by associated p101 (Stephens et al. 1997) or p84 (Suire et al. 2005) regulatory subunits, but direct regulation of the PI3K{gamma} enzyme by ß{gamma}-subunits has also been reported (Leopoldt et al. 1998). Much less clear and more controversial is the manner in which PI3K is activated by GPCRs in tissues where PI3K{gamma} is not expressed, or is present only at low levels. In many cases, activation occurs by transactivation of receptor tyrosine kinases (Daub et al. 1996) followed by the above-detailed mechanism, but this is not the sole means by which GPCRs activate PI3Ks. It is also not known what determines which of the class I PI3Ks ({alpha},ß,{delta}) is activated and which splice form of the p85/p55 regulatory subunit associates with them. Deletion of either PI3K{alpha} or ß is lethal (Bi et al. 1999, 2002), as is the elimination of all the splice forms of the p85/55{alpha} subunits (Fruman et al. 2000), but not of the p85{alpha} form alone (Terauchi et al. 1999), indicating a level of complexity that is still far from being understood. Impairment of PI3K signaling has prominent effects on insulin signaling (Terauchi et al. 1999), and recent studies indicate that the stochiometry between the p85 and p110 subunits, together with the direct interaction of the free p85 subunit with IRS-1, is a major factor determining the insulin responsiveness of the cells (Luo et al. 2005).

Activation of PI3K by estrogens via ligand-dependent association of ER{alpha} with the p85 regulatory subunit has been demonstrated (Simoncini et al. 2000). More recently, a heptahelical receptor, GPR30, which is located in the ER, was shown to respond to estrogen stimulation, leading to the activation of PI3K in the nucleus, as indicated by the translocation of the Akt PH-domain to the nucleus (Revankar et al. 2005). Many questions remain to be answered about this intriguing effect, but it appears to be a new paradigm in steroid hormone action that is not mediated by the classical nuclear receptors.

The main downstream signaling pathway from PI3Ks proceeds via the Akt protein kinase (Franke et al. 1997) and its upstream regulator kinase, PDK1 (Alessi et al. 1997). These kinases are master regulators of a whole range of cellular processes related to glucose metabolism, protein synthesis and cell division, and also represent the main antiapoptotic pathway. Detailed coverage of these processes in endocrine and metabolic regulation is beyond the scope of this review, but can be found elsewhere (Mora et al. 2004).

Receptor trafficking and its regulation by phosphoinositides

Many cell-surface receptors undergo ligand-induced endocytosis mostly (but not exclusively) by a clathrin-mediated internalization process that shares many of the characteristics of the endocytosis and recycling of nutrient receptors (Brown & Goldstein 1979). The sorting of the receptors into clathrin-coated pits is mediated by interaction of the receptor with clathrin-adapter proteins. Several adapter proteins have been identified, including the tetrameric adapters, AP-(2–4), the monomeric adapters such as AP-180 (or its nonneural form, CALM), the Dab1/ARH and the GGA proteins. Many of these adapters exert their effects at intracellular membranes (Owen et al. 2004), when they recognize specific sequences (sorting motifs) within the intracellular segments of nutrient receptors or RTKs. They also bind to clathrin, thereby bringing the receptors to the site of clathrin assembly (Fig. 4Go). Several sorting motifs have been identified in receptors, some containing Tyr, such as the NPxY or the Yxx{Phi} sequences, and others containing Leu/Ile residues, such as the D/ExxxL/I or DxxLL motifs (Bonifacino & Traub 2003). In the case of GPCRs, the common adapter proteins are ß-arrestins which bind to GPCR tails that are Ser/Thr phosphorylated by G protein receptor kinases (GRKs) (Lefkowitz 1993). Phosphorylation of GPCR tails by GRKs is greatly facilitated by the binding of agonist ligands, and it accounts for the ligand-dependence of GPCR internalization. The role of receptor internalization is obvious in the case of nutrient receptors but is less clear in the case of hormone receptors. For this latter, it is an important mechanism for regulating the number of available receptors on the cell surface, and it also eliminates activated receptors that often undergo degradation (Dikic 2003). There is also increasing evidence that some internalized receptors may continue to signal in the endocytic compartments (Luttrell & Lefkowitz 2002).


Figure 4
View larger version (32K):
[in this window]
[in a new window]
 
Figure 4 The general scheme of endocytosis from the plasma membrane. Transmembrane proteins (e.g. receptors) associate with adapter proteins capable of recognizing the internalization signal (usually within their membrane-adjacent cytoplasmic sequence). (Often, a covalent modification, such as phosphorylation or ubiquitination, takes place at these sites on the transmembrane proteins – not shown here.) The adapter protein interaction is also aided by the presence of membrane phosphoinositides and requires an active small GTP-binding protein (such as Arfs or Rabs). The adapter protein also binds clathrin, thereby recruiting the protein into clathrin-coated pits. Several adapter proteins have been shown to bind phosphoinositides, which, in most cases, are the most abundant PtdIns(4,5)P2. Once the vesicles are pinched off (clathrin-coated vesicles, CV), this lipid is no longer demonstrable in the vesicles and is replaced by 3-phosphorylated inositides, contributing to a new identity of the vesicles. Recent studies also indicate that PtdIns(3,4,5)P3 formed in the membrane can be a source of 3-phosphorylated lipids in the endosomes after sequential dephosphorylations by vesicle-associated phosphatases that remove the 5- and 4- phosphates (Ivetac et al. 2005, Shin et al. 2005). Multivesicular bodies are formed from early endosomes (EE) after inward invagination and budding, and PtdIns(3,5)P2 is a critical component of this process (see text for more details).

 
It is quite remarkable that many of the proteins that participate in the internalization process contain binding sites for phosphoinositides. With the exception of the GGAs, all of the above-mentioned clathrin-adapter proteins have been shown to contain one or more phosphoinositide-binding motifs (Owen et al. 2004). Some GRKs (such as GRK2 and 3) contain a pleckstrin-homology domain that is important for the membrane recruitment of the enzymes (Pitcher et al. 1998), but the phospholipid species involved in their regulation is not yet known (Carman et al. 2000). Recently, ß-arrestins were shown to contain phosphoinositide-binding regions that are important for GPCR internalization (Gaidarov et al. 1999, Lee et al. 2003). Finally, the GTP-binding protein, dynamin, which is critical for pinching off internalized vesicles from the plasma membrane, is also known to contain a PH domain. In this case, mutation of the residues essential for lipid binding has a dominant negative effect on receptor endocytosis (e.g. Lee et al. 1999). From the presence of these domains in the above proteins and their ability to bind phosphoinositides in vitro, it is widely assumed that phosphoinositides regulate receptor endocytosis. Mutagenesis studies targeting the lipid-binding regions of the proteins support this assumption, but few studies are available on the question of whether modifying lipid production would affect receptor trafficking. Wortmannin-sensitive (i.e., type III PI4K-synthesized) PtdIns(4)P and PtdIns(4,5)P2 pools support muscarinic and ß2-adrenergic receptor endocytosis (Sorensen et al. 1998), and the plasma membrane recruitment of AP-2 protein and transferrin receptor endocytosis correlates with PIP5KIß activity (Padron et al. 2003). In general, it is not certain which phosphoinositide species regulates any particular step in the complex process of endocytosis. Because of its abundance and in vitro binding to many of the above domains, PtdIns(4,5)P2 is considered the most important inositide in receptor endocytosis. Although several reports have indicated that PI 3-kinases are also agents in this process (Joly et al. 1994, Naga Prasad et al. 2002), pharmacologic blockade of PI3Ks does not dramatically influence the early steps of receptor internalization (Hunyady et al. 2002). Most recently, the protein kinase activity of PI3K{gamma} via phosphorylation of tropomyosin was shown to be critical for ß-adrenergic receptor endocytosis (Naga Prasad et al. 2005).

Fate of the internalized receptors

It is also well documented that the subsequent fate of internalized receptors is highly dependent on processes regulated by PI3Ks. After reaching early endosomes, a large proportion of receptors recycle back to the plasma membrane via a vesicular mechanism involving Rab4 and Rab5 GTPases (Seachrist et al. 2000, Hunyady et al. 2002, Dale et al. 2004). This rapid recycling process is inhibited by the PI 3-kinase inhibitors, wortmannin and LY294002, leading to the accumulation of the receptors in large endocytic vesicles (Shpetner et al. 1996, Hunyady et al. 2002). A fraction of the transferrin receptors and some GPCRs are also sorted into another compartment, called recycling endosomes, that is positive for Rab11 GTPase, and from which there is a significantly slower recycling to the cell surface by a process more resistant to PI 3-kinase inhibitors (Hunyady et al. 2002, van Dam et al. 2002). Interestingly, a group of GPCRs very rapidly recycle back to the cell surface after internalization, and these receptors are not sorted into, and do not take ß-arrestin, to ‘deeper’ compartments (Zhang et al. 1999). One of the most exciting ‘organelles’ of the internalization and recycling pathway is the multivesicular body (MVB), a site for molecular decisions on whether receptors recycle or undergo degradation. Ubiquitination of receptors often determines their fate. Mono-ubiquitination (sometimes at multiple sites) has been shown to be important for internalization and targeting of activated RTKs, such as the EGFR to the inner membrane of the MVB and subsequent lysosomal degradation (Hicke 2001, Katzmann et al. 2002, Haglund et al. 2003). This process is to be distinguished from poly-ubiquitination (where the added ubiquitin is further ubiquitinated multiple times) of soluble proteins that are targeted for proteasomal degradation (Bonifacino & Weissman 1998), although the distinction between the two kinds of ubiquitination is not always clear. Unlike transferrin receptors, some GPCRs also appear at the MVB during their recycling or degradation (Hunyady et al. 2002), and also have been shown to be ubiquitinated (Marchese & Benovic 2001, Shenoy et al. 2001). The role and significance of GPCR ubiquitination in the endocytic and recycling process is not as well understood as for RTKs. 3-Phosphorylated inositides are principal regulators of the sorting process along the endocytic pathway. Class III PI3Ks generate PtdIns(3)P, which contributes to the recruitment to endocytic vesicles of proteins containing FYVE, or PX domains such as Hrs or sorting nexins, respectively. These proteins are important in cargo selection and vesicle dynamics. PtdIns(3)P is also converted to PtdIns(3,5)P2 by the PIKfyve enzyme (Shisheva et al. 1999) (also termed type III PIP kinase). In Saccharomyces cerevisiae, this kinase, termed Fab1p, is also needed for protein sorting into the MVB (Odorozzi et al. 1998).

These selected examples illustrate the complexity of the phosphoinositide requirement of the endocytic and sorting process, and highlight the magnitude of the task that remains to be completed in clarifying the molecular details and biologic importance of receptor endocytosis in endocrine functions.


    Phosphoinositides and ion channels
 Top
 Abstract
 Introduction
 Receptor-mediated InsP3...
 Cell-surface receptors and PI3K...
 Phosphoinositides and ion...
 Phosphoinositides and exocytosis
 Cellular lipid homeostasis and...
 Nuclear receptors, nuclear...
 Concluding remarks
 References
 
The relationship between phosphoinositide turnover and Ca2+ signaling has long been firmly established, and for a while the only debate was about which was the consequence of the other (Cockcroft 1981, Michell 1982). However, the discovery of InsP3-mediated Ca2+ release from internal pools has clarified the primary connection between them. Importantly, Ca2+ also enters the cells via Ca2+ channels located in the plasma membrane, and initially a distinction was made between voltage-gated Ca2+ channels, which mostly regulate the functions of ‘excitable’ cells, and non-voltage-gated Ca2+ influx pathways (or receptor-regulated Ca2+ channels) working in nonexcitable and endocrine cells. Although this distinction has not persisted very long (e.g., the presence of voltage-gated Ca2+ channels in endocrine cells has become common knowledge), the molecular entities behind the Ca2+ entry mechanism(s), described as ‘capacitative’ Ca2+ entry pathway or store-operated Ca2+ entry (SOC) (Putney 1986), has remained elusive.

All nonexcitable cells display increased Ca2+ influx that falls within the criteria of capacitative or SOC, after activation by a ‘calcium-mobilizing’ stimulus (Putney 1986). After decades of studies to identify the Ca2+ channels that underlie this phenomenon, it is still questionable whether a single molecular entity is responsible for the enhanced Ca2+ influx observed after emptying of the intracellular Ca2+ stores (Parekh & Putney 2005). The current activated by the release of Ca2+ stores is termed ICRAC (calcium release-activated current) (Hoth & Penner 1992), but its molecular equivalent is still unresolved, as is the question of whether ICRAC is ‘the current’ corresponding to SOC (see Parekh & Putney (2005) for an excellent recent review). The Ca2+ channel underlying the Drosophila transient receptor potential (Trp) in the fly photoreceptor was proposed to be a channel corresponding to SOC (Wes et al. 1995). After cloning of the mammalian homologs of these proteins (TrpC1–7, ‘C’ stands for classical), a large number of studies addressed this question. Of the seven TrpC channels, most data were gathered for TrpC1 and TrpC3 channels. Overexpression of TrpC1 channels yields a nonselective Ca2+-permeable conductance that moderately increases Ca2+ influx after store depletion in some studies (Zhu et al. 1996), but not in others (Lintschinger et al. 2000). This discrepancy could be due to the fact that TrpC1 proteins require coexpression of other Trp channels (such as TrpC4 and -5) to traffic properly to the plasma membrane (Strubing et al. 2001). Downregulation or elimination of TrpC1 channels at the cellular level also indicates that they are at least partially responsible for store-operated Ca2+ influx (Liu et al. 2003) and ICRAC (Mori et al. 2002).

Studies on TrpC3 channels provided additional insights into the connection between Ca2+ release and influx. Early studies suggested that these channels are regulated by Ca2+ and diacylglycerol (and thereby responded to agonist stimulation), but not by store depletion (Lintschinger et al. 2000). However, other studies have shown that TrpC3 channels do respond to store depletion and that they physically interact with InsP3 receptors, providing experimental support for the previously hypothetical conformational-coupling model of SOC (Kiselyov et al. 1998). It is very likely that Trp channel behavior depends on the presence of other Trp channels (or of associated proteins) in a particular cell, and that cells display a great variety of Ca2+ influx characteristics, depending on the composition of the molecular complex responsible for the store-operated influx phenomenon in specific cell types. This may explain why overexpression studies with the various Trp channels yield apparently discordant information. A detailed, up-to-date review of all Trp channels is given by Putney (2004). Very recent data identify STIM1, an ER-resident, single-transmembrane protein with a Ca2+-sensing luminal domain, as a critical component of SOC (Liou et al. 2005, Roos et al. 2005). STIM1 is not a channel itself, but it may finally provide us with a thread from which the SOC phenomenon will be deciphered. There is very little information about direct regulation of TrpC channels by phosphoinositides, but findings with members of other Trp channel families (see below) indicate that this question should be further investigated.

Curiously, the first ion channels for which phosphoinositide regulation was described were not Ca2+ channels, but members of the inwardly rectifying (Kir) potassium channel family (Hilgemann & Ball 1996). Some Kir channels were shown to be regulated by the ß{gamma}-subunits of heterotrimeric G proteins (GIRKs) (Krapivinsky et al. 1995) and PtdIns(4,5)P2 (Huang et al. 1998, Zhang et al. 1999) and became the prototypical examples. A number of studies followed that showed phosphoinositide regulation of other ion channels. These included other potassium channels, such as the M-current (Suh & Hille 2002) and the underlying KCNQ channels (Zhang et al. 2003), and the two-pore domain K+ channels (Chemin et al. 2005, Lopes et al. 2005). Among Ca2+ channels, members of the Trp family (other than TrpCs) have been shown to be regulated by PtdIns(4,5)P2. As shown for the TrpM5, -7 and -8 channels, PtdIns(4,5)P2 is necessary for channel activity (Runnels et al. 2002). In the case of TrpM8, both cooling and addition of activator ligands, such as menthol, alter the lipid affinity of the channel. The region responsible for lipid regulation has been mapped within the so-called Trp-domain (Rohacs et al. 2005). Other Trp channels, such as the vanilloid receptor (TrpV1), are also regulated by PtdIns(4,5)P2 (Chuang et al. 2001), and this lipid was found to be essential for the recovery of the TrpV1 channel from desensitization (Liu et al. 2005). The intimate relationship between some of these channel proteins and PLC enzymes strongly suggests that the Ca2+ that enters via Trp channels controls local PtdIns(4,5)P2 levels, thereby regulating channel activity by a local feedback regulation. Whether this local control is a general principle governing the function of other Trp channels, including the ‘classical’ TrpC channels discussed above, remains to be determined.

A further emerging theme in Ca2+ (and other) channel control is that channels located in intracellular membrane compartments are inserted into the plasma membrane by a regulated process quite reminiscent of the GLUT4 glucose transporter insertion into the plasma membrane after insulin stimulation. It has been recently shown that growth factors enhance the insertion of TrpC5 channels from a vesicular pool by a PI3K- and Rac1-mediated mechanism that also involves PIP5KI{alpha} (Bezzerides et al. 2004). Similarly, PI3K-dependent trafficking of voltage-gated Ca2+ channels to the plasma membrane has been recently reported (Viard et al. 2004). Intriguingly, a previously described curious stimulatory effect of PLC{gamma}1 expression on the activity of TrpC3 channels (that oddly did not require the PLC activity of the protein) has also been attributed to enhanced surface expression of the channels (Patterson et al. 2002). In this newly discovered process, one of the 1/2 PH-domains of PLC{gamma}1 and a half-PH domain located within the intracellular tails of TrpC channels form an ‘intermolecular PH domain’ providing phosphoinositide interaction and stabilizing the channel at the plasma membrane (van Rossum et al. 2005). These new observations demonstrate that, in addition to the acute regulation of channel activities in the plasma membrane by rapid changes in phosphoinositides, these lipids also control the trafficking and distribution of the channels between the various membranes, adding a new level of complexity to the control of Ca2+ (and other ion) fluxes of the cell.


    Phosphoinositides and exocytosis
 Top
 Abstract
 Introduction
 Receptor-mediated InsP3...
 Cell-surface receptors and PI3K...
 Phosphoinositides and ion...
 Phosphoinositides and exocytosis
 Cellular lipid homeostasis and...
 Nuclear receptors, nuclear...
 Concluding remarks
 References
 
While regulated secretion is one of the key features of many endocrine and neuroendocrine cells, it is also found in other cells such as those of the immune system. This process is also called dense-core vesicle (DCV) exocytosis to distinguish it from the small synaptic vesicle (SV) exocytosis found in presynaptic terminals, although the underlying processes have many common features (Martin 2003, Wenk & De Camilli 2004). DCVs containing cargo to be secreted undergo maturation that increases their competence to dock, and ultimately fuse, with the plasma membrane when a rapid rise in Ca2+ concentration triggers the fusion process. Some of the mature granules under the membrane will dock to the plasma membrane, but these predocked vesicles still have to undergo ‘priming’ to become the ‘readily releasable pool’ that is first to be fused upon stimulation (Fig. 5Go). The prefusion process of ‘priming’ has been shown to be ATP-dependent and to involve the synthesis of PtdIns(4,5)P2 (Eberhard et al. 1990, Hay & Martin 1993, Hay et al. 1995). Purification of the cytosolic components required for ATP-dependent priming has led to the identification of the PI-transfer protein (Hay & Martin 1993) and a PIP 5-kinase (Hay et al. 1995), but the PI4K that is needed for PtdIns(4,5)P2 generation has never been identified. It is noteworthy that the first successful cloning of the type II PI4K resulted from the purification of a chromaffin granule-associated PI4K (Barylko et al. 2001). Whether this enzyme supports the process of exocytosis is yet to be determined.


Figure 5
View larger version (24K):
[in this window]
[in a new window]
 
Figure 5 Multiple steps in the exocytic process. Secretory vesicles containing their cargo become docked to the plasma membrane to form the rapidly releasable vesicular pool by maturation. During maturation, which is an ATP-dependent process, these vesicles become ‘primed’, that is, ready for release once the Ca2+-induced triggering takes place. Synthesis of phosphoinositides (probably PtdIns(4,5)P2) is part of the priming process, and the recruitment of the Ca2+-binding regulatory protein CAPS (which also binds PtdIns(4,5)P2) is an essential component of priming. Vesicles are stabilized by the t- and v-snare proteins (syntaxin and VAMP respectively), and they respond to Ca2+ increases via synaptotagmin (a protein also capable of phosphoinositide binding), which ultimately triggers the conformational change(s) leading to pore opening and cargo release. Phosphoinositides as well as Ca2+ increases act at multiple steps, and production of the lipid both at the membrane and on the surface of the vesicles may take place.

 
The PI3K inhibitor, wortmannin (Wm), potently inhibits the degranulation caused by FcR activation in rat basophilic leukaemia (RBL) cells at concentrations that are consistent with inhibition of PI3K enzymes (Yano et al. 1993). However, in other cells, such as pituitary gonadotrophs (Rao et al. 1997), pancreatic ß cells (Straub & Sharp 1996) and PC12 cells (Oda et al. 1997), higher Wm concentrations were found to inhibit secretion, and, where kinetic analysis was performed, Wm selectively eliminated the sustained phase of secretion without affecting its early rapid phase (Rao et al. 1997). These effects of Wm (which were often attributed to MLCK inhibition by early studies) probably result from inhibition of type III PI4K enzymes that are also targets of Wm at the same high concentration range. Wm therefore appears to affect the process of replenishment of the readily releasable pool, at least in some cells. Moreover, a phenylarsine-oxide (PAO)-sensitive PI4K was identified as necessary for secretion in chromaffin cells (Wiedemann et al. 1996) and in pancreatic ß-cells (Olsen et al. 2003). While PAO can have several targets other than PI4Ks, among the latter, PI4 KIII{alpha} (another Wm-sensitive PI4K) shows the highest sensitivity to PAO (Balla et al. 2002). Recent evidence suggests that the small Ca2+-binding protein, NCS-1, activates the Wm-sensitive PI4 KIIIß enzyme and regulates priming and formation of the rapidly releasable vesicular pool in pancreatic ß cells (Gromada et al. 2005). Similarly, reducing the levels of PI4 KIIIß (Waselle et al. 2005) or PIP5KI{gamma} (Gong et al. 2005, Waselle et al. 2005) has been shown to inhibit dense-core vesicle exocytosis. Recent studies have also indicated that PI3KC2{alpha}, by producing PtdIns(3)P, is also involved in neurosecretory granule exocytosis, adding 3-phosphorylated inositides to the list of potential regulators of the priming process (Meunier et al. 2005).

The regulatory role of phosphoinositides in synaptic vesicle release and recycling has also been well documented. Both synaptojanin-1, a phosphoinositide 5-phosphatase (McPherson et al. 1996), and PIP5KI{gamma} (Wenk et al. 2001) have been shown to associate with synaptic vesicles, and knockout studies have confirmed that these enzymes are essential for normal synaptic functions, and have a role at multiple steps in synaptic vesicle exocytosis and recycling (Cremona et al. 1999, Di Paolo et al. 2004). Of the PI 4-kinases, PI4KII{alpha} was shown to associate with synaptic vesicles (Guo et al. 2003). On the other hand, the Drosophila homolog of NCS-1, originally named frequenin and described as a major determinant of synaptic development and plasticity (Pongs et al. 1993), is a major regulator of the PI4KIIIß protein (Weisz et al. 2000), as well as its yeast homolog, Pik1p (Hendricks et al. 1999). This suggests that there is a link between PI4KIIIß function and synaptic transmission. It would not be surprising if both type-II and type-III PI4Ks were found to be important enzymes at distinct steps in the complex process of synaptic vesicle exocytosis and recycling.

Regarding the role of phosphoinositides in exocytosis, two additional questions remain to be answered. The first is whether the phosphoinositides are required on the surface of the secretory vesicles or at the plasma membrane, or perhaps in both locations. Initial reports have indicated that PtdIns(4,5)P2 is needed on the surface of the vesicles where the presence of the enzymes has been demonstrated (Martin et al. 1997). However, studies using the PLC{delta}1PH-GFP fusion protein to image PtdIns(4,5)P2 distribution failed to detect this lipid on the vesicular surface (Holz et al. 2000), indicating instead a significant increase in PtdIns(4,5)P2 at the contact sites in the plasma membrane associated with the vesicle fusion process (Holz et al. 2000, Aoyagi et al. 2005). A recent report has established that plasma membrane PtdIns(4,5)P2 levels are a determinant of the size of the readily releasable pool in chromaffin cells (Milosevic et al. 2005). Nevertheless, these observations do not rule out additional function(s) of PtdIns(4,5)P2 at the surface of secretory vesicles. Another question relates to the identity of the molecules that are the targets of PtdIns(4,5)P2. CAPS-1 (Ca2+-sensitive activator protein of secretion) has been identified as a crucial factor in DCV exocytosis that acts between docking and fusion (Walent et al. 1992). This protein was shown to be a PtdIns(4,5)P2-binding protein (Loyet et al. 1998) whose recruitment to the plasma membrane depended on PtdIns(4,5)P2 levels (Grishanin et al. 2004). Interestingly, while CAPS-1 has a central PH domain and PH domains generally serve as lipid-binding modules (Lemmon & Ferguson 2000), the CAPS-1 PH domain is not the principal lipid-binding site of the molecule (Grishanin et al. 2004). Other proteins have also been suggested as targets of phosphoinositides in regulated secretion. These include the Ca2+-sensitive SNARE-regulator protein, synaptotagmin, which binds inositides with its C2B domain (Schiavo et al. 1996, Bai et al. 2004); the Mint proteins (Okamoto & Sudhof 1997); and Rabphilin (Chung et al. 1998). Synaptotagmins have key roles in the Ca2+-triggered fusion process (Tucker & Chapman 2002), and their phosphoinositide binding has other functions than vesicle priming, again enforcing the idea that phosphoinositides contribute to the regulation of the secretory process in multiple ways.


    Cellular lipid homeostasis and phosphoinositides
 Top
 Abstract
 Introduction
 Receptor-mediated InsP3...
 Cell-surface receptors and PI3K...
 Phosphoinositides and ion...
 Phosphoinositides and exocytosis
 Cellular lipid homeostasis and...
 Nuclear receptors, nuclear...
 Concluding remarks
 References
 
Although maintenance of cellular lipid homeostasis is a well-recognized function of all eukaryotic cells, traditionally only some of its aspects are subjects of endocrine research. This is in spite of the fact that lipid metabolism at the level of the whole organism is a central topic of endocrinology. The role or roles of phosphoinositides in the regulation of lipid synthesis and transport are not widely recognized, but recent findings suggest that these processes are also under the control of phosphoinositides. Studies on PH domains that recognize specific inositol lipids have revealed that a special subgroup of PH domains can bind PtdIns(4)P with remarkable specificity (Dowler et al. 2000). Proteins whose PH domains belong to this subgroup are the oxysterol-binding protein (OSBP), the ceramide-transfer protein (CERT) (Hanada et al. 2003) and the FAPP1 and FAPP2 proteins (Godi et al. 2004). With the exception of the FAPP1 protein, which appears to be a truncated adapter protein, all of these are lipid-binding/transfer proteins. The functions of OSBPs and their related proteins (ORPs) are mostly unknown, but they contain a lipid-binding motif that binds oxysterols or other phospholipids and a PH domain for interaction with membrane phosphoinositides (Lehto & Olkkonen 2003, Olkkonen & Lehto 2004). Oxysterols are among the most potent regulators of the transcription of genes that contribute to cholesterol synthesis and transport (Brown & Goldstein 1974, Olkkonen & Lehto 2004). OSBP overexpression increases cholesterol biosynthesis in chinese hamster ovary (CHO) cells (Lagace et al. 1997), and depletion of cholesterol or addition of 25-OH cholesterol promotes the association of OSBP with the Golgi complex (Ridgway et al. 1992, Storey et al. 1998). Since cholesterol biosynthesis is largely controlled by the SREBP transcription factor, whose nuclear translocation depends on its proteolytic cleavage in the Golgi complex (Brown & Goldstein 1999), the regulation of SREBP vesicular transport from the ER to the Golgi complex is a crucial step in cholesterol homeostasis and one that is likely to be controlled by PI 4-kinase(s). However, little is known about the connection between OSBP proteins and cholesterol homeostasis, and the involvement of phosphoinositides in SREBP trafficking.

More is known about the recently identified CERT protein, which is essential for the transport of ceramide from the site of its synthesis in the ER to the Golgi, where its conversion to sphingomyelin takes place (Perry & Ridgway 2005). CERT also contains a PH domain that binds PtdIns(4)P, and a single-point mutation within the PH domain that eliminates PtdIns(4)P binding is sufficient to render CERT completely dysfunctional (Hanada et al. 2003). PtdIns(4)P, therefore, is emerging as an important lipid regulator of the synthesis of sphingomyelin via its participation in the control of ceramide transport between the ER and the Golgi. It is a fascinating question why sufficient amounts of ceramide cannot reach the Golgi via the highly dynamic vesicular transport process that exists between the two organelles. This also suggests that ceramide is excluded from the budding CopII vesicles destined for the Golgi, probably because it is bound to a yet unidentified ER protein. The FAPP2 protein also contains a putative glycolipid-binding domain, but its natural ligand-binding partner is not known. The role (if any) that FAPP2 plays in cellular lipid metabolism, and whether the effects of FAPP2 knockdown on trafficking are related to its lipid-transport function, are also not known (Godi et al. 2004, Vieira et al. 2005).

Another indication of the importance of PtdIns(4)P in phospholipid synthesis comes from yeast studies. Synthesis of the aminophospholipid, phosphatidyl-ethanolamine (PE), via decarboxylation of ER-derived phosphatidylserine (PS), takes place either in the mitochondria or in Golgi membranes (Voelker 2005). PS, therefore, has to be transferred to those membranes in order to be decarboxylated, and genetic studies have shown that Stt4p (the yeast homolog of PI4KIII alpha) is a regulatory component of this process at the ER/Golgi (but not at the mitochondrial) site (Trotter et al. 1998). It is not yet known why the Stt4p kinase is needed for lipid transfer or whether it acts at the donor or acceptor membrane site. It also remains to be seen whether a similar regulation of aminophospholipid synthesis by PI 4-kinases or by other phosphoinositides is present in higher organisms.

Sec14p, the yeast PI/PC-TP, is as an essential component of the secretion process from the Golgi in Saccharomyces cerevisiae, and also functions in phosphatidylcholine (PC) metabolism and maintains DAG levels in the Golgi (Routt & Bankaitis 2004). There is an intimate relationship between Sec14p and PtdIns(4)P levels within the Golgi, since inactivation of the Sac1p inositol lipid phosphatase (Guo et al. 1999) can ‘bypass’ Sec14p defects (Whitters et al. 1993). Mammalian PITP proteins come in various forms: in addition to PITP{alpha} and -ß, a highly homologous PITP module is found in some of the larger RdgB proteins that are homologs of the Drosophila retinal degeneration protein (Vihtelic et al. 1993). Two of the PITPs, the small PITPß and large RdgB{alpha}1, are Golgi-localized proteins, and the latter was recently shown to be critical for Golgi morphology and function by controlling DAG levels (Litvak et al. 2005). In this regard, the lack of RdgB{alpha}1 in mammalian cells causes a defect similar to that seen in the yeast SEC14. The small PITPß appears to be an essential gene in the mouse, but PITP{alpha} knockout mice are viable with prominent defects in the transport of re-esterified triglycerides from the ER in enterocytes and a similarly defective lipid handling of hepatocytes (Bankaitis et al. 2004). Reduced levels of PITP{alpha} are responsible for the early-onset neurodegeneration described in the vibrator mouse (Hamilton et al. 1997). PITPs are clearly an exciting group of proteins on the border of phospholipid metabolism and vesicular trafficking, and will surely surprise us with novel functions in the near future.


    Nuclear receptors, nuclear signaling and inositol phospholipids
 Top
 Abstract
 Introduction
 Receptor-mediated InsP3...
 Cell-surface receptors and PI3K...
 Phosphoinositides and ion...
 Phosphoinositides and exocytosis
 Cellular lipid homeostasis and...
 Nuclear receptors, nuclear...
 Concluding remarks
 References
 
Steroid and thyroid hormones that bind to intracellular receptors and regulate the transcription of their target genes in the nucleus seem to defy the developments of phosphoinositide research. Although a fraction of almost all of the inositide kinases and PLCs have been shown to be present in the nucleus under certain conditions (Payrastre et al. 1992, Manzoli et al. 2005), and a separate nuclear phosphoinositide system has long been postulated (Irvine 2003), the link between the latter and the transcriptional apparatus has not been forthcoming. This gap began to narrow when genetic studies in yeast revealed that two inositol polyphosphate (IP) kinases, Ipk1 and Ipk2, are involved in mRNA export, chromatin remodeling and DNA metabolism (Odom et al. 2000, Shears 2004). These enzymes are critically important for the synthesis of highly phosphorylated inositols, such as InsP5 and InsP6, and also for the production of the pyrophosphorylated PP-InsP4 and PP-IP5, but it is not known at this point which (if any) of the highly phosphorylated inositols serves as an active regulatory species. Recent studies showed that the inositol pyrophosphates also regulate telomere length (Saiardi et al. 2005, York et al. 2005). Most recently, inositol multikinase, the mammalian homolog of Ipk2, was found to function as a wortmannin-insensitive PI 3-kinase in the nucleus. This observation raises the question of whether the lipids or the soluble inositol phosphates are the most important regulatory products of the enzyme (Carroll et al. 2004). In a separate line of research, structural characterization of the transcription factor, TFIIH, unveiled the presence of a PH domain in the molecule (Gervais et al. 2004). Moreover, an inositide-binding PHD domain was described in the chromatin-associated protein, ING2 (Gozani et al. 2003). The transcription factor Tubby, which, when mutated in mice, causes obesity, insulin resistance and sensory deficits (Carroll et al. 2004), was also shown to interact within its carboxy-terminal domain with plasma membrane PtdIns(4,5)P2. Only upon hydrolysis of the lipid does Tubby become free to translocate to the nucleus (Santagata et al. 2001). The recent discovery of nuclear orphan receptors that bind phospholipids (Li et al. 2005), including PtdIns(3,4,5)P3, as ligands (Krylova et al. 2005) is the latest addition to a list of nuclear proteins potentially regulated by phosphoinositides. It is expected that this area of research will greatly expand in the near future, putting nuclear events on a par with membrane-associated signaling processes as regulatory targets of phosphoinositides.


    Concluding remarks
 Top
 Abstract
 Introduction
 Receptor-mediated InsP3...
 Cell-surface receptors and PI3K...
 Phosphoinositides and ion...
 Phosphoinositides and exocytosis
 Cellular lipid homeostasis and...
 Nuclear receptors, nuclear...
 Concluding remarks
 References
 
These examples of inositol lipid-regulated processes contributing to the complex cellular responses to hormones and neurotransmitters represent only a limited selection from the multitude of actions of phosphoinositides. The purpose of discussing them in this context was to identify areas of interest and to facilitate the incorporation of phosphoinositides as important topics in endocrine research. Over the last decade, it has become increasingly clear that the molecular elements of the classical messenger cascades, such as receptors, G proteins, ion channels and ‘effectors’, such as PLCs and A- or G- cyclases, are actively organized within the cell in the relevant membrane compartments. Phosphoinositides are at least as important in the trafficking and organization of signaling complexes as they are in the rapid generation of intracellular messengers. It is not too difficult to foresee a great expansion of knowledge in this research area and that cellular endocrinology will be an active contributor to, as well as a beneficiary of, this expansion.


    Acknowledgements
 
I thank Dr Kevin J Catt (NICHD, NIH) for his critical reading of the manuscript and helpful suggestions. This research is supported by the Intramural Research Program of the National Institute of Child Health and Human Development of the National Institutes of Health. The author declares that there is no conflict of interest that would prejudice the impartiality of this scientific work.


    References
 Top
 Abstract
 Introduction
 Receptor-mediated InsP3...
 Cell-surface receptors and PI3K...
 Phosphoinositides and ion...
 Phosphoinositides and exocytosis
 Cellular lipid homeostasis and...
 Nuclear receptors, nuclear...
 Concluding remarks
 References
 
Abel K, Anderson RA & Shears SB 2001 Phosphatidylinositol and inositol phosphate metabolism. Journal of Cell Science 114 2207–2208.[Medline]

Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB & Cohen P 1997 Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Current Biology 7 261–269.[CrossRef][Web of Science][Medline]

Aoyagi K, Sugaya T, Umeda M, Yamamoto S, Terakawa S & Takahashi M 2005 The activation of exocytotic sites by the formation of phosphatidylinositol 4,5-bisphosphate microdomains at syntaxin clusters. Journal of Biological Chemistry 280 17346–17352.[Abstract/Free Full Text]

Bai J, Tucker WC & Chapman ER 2004 PIP2 increases the speed of response of synaptotagmin and steers its membrane-penetration activity toward the plasma membrane. Nature Structural and Molecular Biology 11 36–44.

Balla T 1998 Phosphatidylinositol 4-kinases. Biochimica Biophysica Acta 1436 69–85.[Medline]

Balla A, Tuymetova G, Barshishat M, Geiszt M & Balla T 2002 Characterization of type II phosphatidylinositol 4-kinase isoforms reveals association of the enzymes with endosomal vesicular compartments. Journal of Biological Chemistry 277 20041–22050.[Abstract/Free Full Text]

Balla A, Tuymetova G, Tsiomenko A, Varnai P & Balla T 2005 A plasma membrane pool of phosphatidylinositol 4-phosphate is generated by phosphatidylinositol 4-kinase type-III alpha: studies with the PH domains of the oxysterol binding protein and FAPP1. Molecular Biology of the Cell 16 1282–1295.[Abstract/Free Full Text]

Bankaitis VA, Cortese J, Phillips SE & Alb JG Jr 2004 Phosphatidylinositol transfer protein function in the mouse. Advances in Enzyme Regulation 44 201–218.[Web of Science][Medline]

Barylko B, Gerber SH, Binns DD, Grichine N, Khvotchev M, Sudhof TC & Albanesi JP 2001 A novel family of phosphatidylinositol 4-kinases conserved from yeast to humans. Journal of Biological Chemistry 276 7705–7708.[Abstract/Free Full Text]

Berridge MJ 1984 Inositol trisphosphate and diacylglycerol as intracellular messengers. Biochemical Journal 220 345–360.[Web of Science][Medline]

Berridge MJ, Downes CP & Hanley MR 1989 Neural and developmental actions of lithium: a unifying hypothesis. Cell 59 411–419.[CrossRef][Web of Science][Medline]

Bezprozvanny I, Watras J & Ehrlich BE 1991 Bell-shaped calcium-response curves of Ins(1,4,5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature 351 751–754.[CrossRef][Medline]

Bezzerides VJ, Ramsey IS, Kotecha S, Greka A & Clapham DE 2004 Rapid vesicular translocation and insertion of TRP channels. Nature Cell Biology 6 709–720.[CrossRef][Web of Science][Medline]

Bi L, Okabe I, Bernard DJ, Wynshaw-Boris A & Nussbaum RL 1999 Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110 alpha subunit of phosphoinositide 3-kinase. Journal of Biological Chemistry 274 10963–10968.[Abstract/Free Full Text]

Bi L, Okabe I, Bernard DJ & Nussbaum RL 2002 Early embryonic lethality in mice deficient in the p110 beta catalytic subunit of PI 3-kinase. Mammalian Genome 13 169–172.[CrossRef][Web of Science][Medline]

Boehning D & Joseph SK 2000 Direct association of ligand-binding and pore domains in homo- and heterotetrameric inositol 1,4,5-trisphosphate receptors. EMBO Journal 19 5450–5459.[CrossRef][Web of Science][Medline]

Bonifacino JS & Weissman AM 1998 Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annual Review of Cell and Developmental Biology 14 19–57.[CrossRef][Web of Science][Medline]

Bonifacino JS & Traub LM 2003 Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annual Review of Biochemistry 72 395–447.[CrossRef][Web of Science][Medline]

Bosanac I, Alattia JR, Mal TK, Chan J, Talarico S, Tong FK, Tong KI, Yoshikawa F, Furiuchi T, Iwai M et al. 2002 Structure of the inositol 1,4,5-trishphosphate receptor binding core in complex with its ligand. Nature 420 696–700.[CrossRef][Medline]

Bosanac I, Yamazaki H, Matsu-ura T, Michikawa T, Mikoshiba K & Ikura M 2005 Crystal structure of the ligand binding suppressor domain of type 1 inositol 1,4,5-trisphosphate receptor. Molecular Cell 17 193–203.[CrossRef][Web of Science][Medline]

Brown MS & Goldstein JL 1974 Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol. Journal of Biological Chemistry 249 7306–7314.[Abstract/Free Full Text]

Brown MS & Goldstein JL 1979 Receptor-mediated endocytosis: insights from the lipoprotein receptor system. PNAS 76 3330–3337.[Abstract/Free Full Text]

Brown MS & Goldstein JL 1999 A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. PNAS 96 11041–11048.[Abstract/Free Full Text]

Carman CV, Barak LS, Chen C, Liu-Chen L-Y, Onorato JJ, Kennedy SP, Caron MG & Benovic JL 2000 Mutational analysis of Gß{gamma} and phospholipid interaction with G protein-coupled receptor kinase 2. Journal of Biological Chemistry 275 10443–10452.[Abstract/Free Full Text]

Carroll K, Gomez C & Shapiro L 2004 Tubby proteins: the plot thickens. Nature Reviews. Molecular Cell Biology 5 55–63.[CrossRef][Web of Science][Medline]

Chemin J, Patel AJ, Duprat F, Lauritzen I, Lazdunski M & Honore E 2005 A phospholipid sensor controls mechanogating of the K+ channel TREK-1. EMBO Journal 24 44–53.[CrossRef][Web of Science][Medline]

Chong LD, Traynor-Kaplan A, Bokoch GM & Schwartz MA 1994 The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells. Cell 79 507–513.[CrossRef][Web of Science][Medline]

Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI, Chao MV & Julius D 2001 Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 411 957–962.[CrossRef][Medline]

Chung SH, Song WJ, Kim K, Bednarski JJ, Chen J, Prestwich GD & Holz RW 1998 The C2 domains of Rabphilin3A specifically bind phosphatidylinositol 4,5-bisphosphate containing vesicles in a Ca2+-dependent manner. In vitro characteristics and possible significance. Journal of Biological Chemistry 273 10240–10248.[Abstract/Free Full Text]

Cockcroft S 1981 Does phosphatidylinositol breakdown control the Ca2+-gating mechanism? Trends in Pharmacological Sciences 2 340–342.[CrossRef]

Cremona O, Di Paolo G, Wenk MR, Luthi A, Kim WT, Takei K, Daniell L, Nemoto Y, Shears SB, Flavell RA et al. 1999 Essential role of phosphoinositide metabolism in synaptic vesicle recycling. Cell 99 179–188.[CrossRef][Web of Science][Medline]

Csordas G, Thomas AP & Hajnoczky G 1999 Quasi-synaptic calcium signal transmission between endoplasmic reticulum and mitochondria. EMBO Journal 18 96–108.[CrossRef][Web of Science][Medline]

da Fonseca PC, Morris SA, Nerou EP, Taylor CW & Morris EP 2003 Domain organization of the type 1 inositol 1,4,5-trisphosphate receptor as revealed by single-particle analysis. PNAS 100 3936–3941.[Abstract/Free Full Text]

Dale LB, Seachrist JL, Babwah AV & Ferguson SS 2004 Regulation of angiotensin II type 1A receptor intracellular retention, degradation, and recycling by Rab5, Rab7, and Rab11 GTPases. Journal of Biological Chemistry 279 13110–13118.[Abstract/Free Full Text]

Daub H, Weiss FU, Wallasch C & Ullrich A 1996 Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379 557–560.[CrossRef][Medline]

Dawson AP & Irvine RF 1984 Inositol(1,4,5)trisphosphate-promoted Ca2+ release from microsomal fractions of rat liver. Biochemical Biophysical Research Communications 120 858–864.

Dikic I 2003 Mechanisms controlling EGF receptor endocytosis and degradation. Biochemical Society Transactions 31 1178–1181.[Web of Science][Medline]

Di Paolo G, Moskowitz HS, Gipson K, Wenk MR, Voronov S, Obayashi M, Flavell R, Fitzsimonds RM, Ryan TA & De Camilli P 2004 Impaired PtdIns(4,5)P2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking. Nature 431 415–422.[CrossRef][Medline]

Dowler S, Currie RA, Campbell DG, Deak M, Kular G, Downes CP & Alessi DR 2000 Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities. Biochemical Journal 351 19–31.[CrossRef][Web of Science][Medline]

Eberhard DA, Cooper CL, Low MG & Holz RW 1990 Evidence that the inositol phospholipids are necessary for exocytosis. Biochemical Journal 268 15–25.[Web of Science][Medline]

Franke TF, Kaplan DR, Cantley LC & Toker A 1997 Direct regulation of the Akt protooncogene product by PI(3,4)P2. Science 275 665–668.[Abstract/Free Full Text]

Fruman DA, Meyers RE & Cantley LC 1998 Phosphoinositide kinases. Annual Review of Biochemistry 67 481–507.[CrossRef][Web of Science][Medline]

Fruman DA, Mauvais-Jarvis F, Pollard DA, Yballe CM, Brazil D, Bronson RT, Kahn CR & Cantley LC 2000 Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha. Nature Genetics 26 379–382.[CrossRef][Web of Science][Medline]

Furuichi T, Yoshikawa S, Miyawaki A, Wada K, Maeda N & Mikoshiba K 1989 Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400. Nature 342 32–38.[CrossRef][Medline]

Gaborik Z & Hunyady L 2004 Intracellular trafficking of hormone receptors. Trends in Endocrinology and Metabolism 15 286–293.[CrossRef][Web of Science][Medline]

Gaidarov I, Krupnick JG, Falck JR, Benovic JL & Keen JH 1999 Arrestin function in G protein-coupled receptor endocytosis requires phosphoinositide binding. EMBO Journal 18 871–881.[CrossRef][Web of Science][Medline]

Galvan DL, Borrego-Diaz E, Perez PJ & Mignery GA 1999 Subunit oligomerization, and topology of the inositol 1,4,5-trisphosphate receptor. Journal of Biological Chemistry 274 29483–29492.[Abstract/Free Full Text]

Gervais V, Lamour V, Jawhari A, Frindel F, Wasielewski E, Dubaele S, Egly J-M, Thierry J-C, Kieffer B & Poterszman A 2004 TFIIH contains a PH domain involved in DNA nucleotide excision repair. Nature Structural and Molecular Biology 11 616–622.

Glouchankova L, Krishna UM, Potter BV, Falck JR & Bezprozvanny I 2000 Association of the inositol (1,4,5)-trisphosphate receptor ligand binding site with phosphatidylinositol (4,5)-bisphosphate and adenophostin A. Molecular Cell Biology Research Communication 3 153–158.

Godi A, Di Campi A, Konstantakopoulos A, Di Tullio G, Alessi DR, Kular GS, Daniele T, Marra P, Lucocq JM & De Matteis MA 2004 FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P. Nature Cell Biology 6 393–404.[CrossRef][Web of Science][Medline]

Gong LW, Di Paolo G, Diaz E, Cestra G, Diaz ME, Lindau M, De Camilli P & Toomre D 2005 Phosphatidylinositol phosphate kinase type I gamma regulates dynamics of large dense-core vesicle fusion. PNAS 102 5204–5209.[Abstract/Free Full Text]

Gozani O, Karuman P, Jones DR, Ivanov D, Cha J, Logovskoy AA, Baird CL, Zhu H, Field SJ, Lessnick SL et al. 2003 The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell 114 99–111.[CrossRef][Web of Science][Medline]

Grishanin RN, Kowalchyk JA, Klenchin VA, Ann K, Earles CA, Chapman ER, Gerona RR & Martin TF 2004 CAPS acts at a prefusion step in dense-core vesicle exocytosis as a PIP2 binding protein. Neuron 43 551–562.[CrossRef][Web of Science][Medline]

Gromada J, Bark C, Smidt K, Efanov AM, Janson J, Mandic SA, Webb DL, Zhang W, Meister B, Jeromin A et al. 2005 Neuronal calcium sensor-1 potentiates glucose-dependent exocytosis in pancreatic beta cells through activation of phosphatidylinositol 4-kinase beta. PNAS 102 10303–10308.[Abstract/Free Full Text]

Guillemette G, Balla T, Baukal AJ & Catt KJ 1988 Characterization of inositol 1,4,5-trisphosphate receptors and calcium mobilization in a hepatic plasma membrane fraction. Journal of Biological Chemistry 263 4541–4548.[Abstract/Free Full Text]

Guo J, Wenk MR, Pellegrini L, Onofri F, Benfenati F & De Camilli P 2003 Phosphatidylinositol 4-kinase type IIalpha is responsible for the phosphatidylinositol 4-kinase activity associated with synaptic vesicles. PNAS 100 3995–4000.[Abstract/Free Full Text]

Guo S, Stolz LE, Lemrow SM & York JD 1999 SAC1-like domains of yeast SAC1, INP52, and INP53 and of human synaptojanin encode polyphosphoinositide phosphatases. Journal of Biological Chemistry 274 12990–12995.[Abstract/Free Full Text]

Haglund K, Di Fiore PP & Dikic I 2003 Distinct monoubiquitin signals in receptor endocytosis. Trends in Biochemical Sciences 28 598–603.[CrossRef][Web of Science][Medline]

Hajnoczky G & Thomas AP 1994 The inositol trisphosphate calcium channel is inactivated by inositol trisphosphate. Nature 370 474–477.[CrossRef][Medline]

Hajnoczky G, Robb-Gaspers LD, Seitz MB & Thomas AP 1995 Decoding of cytosolic calcium oscillations in the mitochondria. Cell 82 415–424.[CrossRef][Web of Science][Medline]

Hamilton BA, Smith DJ, Mueller KL, Kerrebrock AW, Bronson RT, van Berkel V, Daly MJ, Kruglyak L, Reeve MP, Nemhauser JL et al. 1997 The vibrator mutation causes neurodegeneration via reduced expression of PITP alpha: positional complementation cloning and extragenic suppression. Neuron 18 711–722.[CrossRef][Web of Science][Medline]

Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M & Nishijima M 2003 Molecular machinery for non-vesicular trafficking of ceramide. Nature 426 803–809.[CrossRef][Medline]

Hardie RC 2003 Regulation of TRP channels via lipid second messengers. Annual Review of Physiology 65 735–759.[CrossRef][Web of Science][Medline]

Hay JC & Martin TFJ 1993 Phosphatidylinositol transfer protein required for ATP-dependent priming of Ca2+-activated secretion. Nature 366 572–575.[CrossRef][Medline]

Hay JC, Fisette PL, Jenkins GH, Fukami K, Takenawa T, Anderson RA & Martin TFJ 1995 ATP-dependent inositide phosphorylation required for Ca2+-activated secretion. Nature 374 173–177.[CrossRef][Medline]

Hendricks KB, Wang BQ, Schnieders EA & Thorner J 1999 Yeast homologue of neuronal frequenin is a regulator of phosphatidylinositol 4-OH-kinase. Nature Cell Biology 1 234–241.[CrossRef][Web of Science][Medline]

Hicke L 2001 A new ticket for entry into budding vesicles –ubiquitin. Cell 106 527–530.[CrossRef][Web of Science][Medline]

Hilgemann DW & Ball R 1996 Regulation of cardiac Na+, Ca2+ exchange and KATP potassium channels by PIP2. Science 273 956–959.[Abstract]

Hinchliffe AK, Ciruela A & Irvine RF 1998 PIPkins, their substrates and their products: new functions for old enzymes. Biochimica Biophysica Acta 1436 87–104.[Medline]

Holz RW, Hlubek MD, Sorensen SD, Fisher SK, Balla T, Ozaki S, Prestwich GD, Stuenkel EL & Bittner MA 2000 A pleckstrin homology domain specific for Ptdins-4,5-P2 and fused to green fluorescent protein identifies plasma membrane Ptdins-4,5-P2 as being important in exocytosis. Journal of Biological Chemistry 275 17878–17885.[Abstract/Free Full Text]

Honda A, Nogami M, Yokozeki T, Yamazaki M, Nakamura H, Watanabe H, Kawamoto K, Nakayama K, Morris AJ, Frohman MA et al. 1999 Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation. Cell 99 521–532.[CrossRef][Web of Science][Medline]

Horowitz LF, Hirdes W, Suh BC, Hilgemann DW, Mackie K & Hille B 2005 Phospholipase C in living cells: activation, inhibition, Ca2+ requirement, and regulation of M current. Journal of General Physiology 126 243–262.[Abstract/Free Full Text]

Hoth M & Penner R 1992 Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 355 353–356.[CrossRef][Medline]

Huang CL, Feng S & Hilgemann DW 1998 Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma. Nature 391 803–806.[CrossRef][Medline]

Hunyady L, Baukal AJ, Gaborik Z, Olivares-Reyes JA, Bor M, Szaszak M, Lodge R, Catt KJ & Balla T 2002 Differential PI 3-kinase dependence of early and late phases of recycling of the internalized AT1 angiotensin receptor. Journal of Cell Biology 157 1211–1222.[Abstract/Free Full Text]

Irvine RF 2003 Nuclear lipid signalling. Nature Reviews. Molecular Cell Biology 4 349–360.[CrossRef][Web of Science][Medline]

Ivetac I, Munday AD, Kisseleva MV, Zhang XM, Luff S, Tiganis T, Whisstock JC, Rowe T, Majerus PW & Mitchell CA 2005 The type Ialpha inositol polyphosphate 4-phosphatase generates and terminates phosphoinositide 3-kinase signals on endosomes and the plasma membrane. Molecular Biology of the Cell 16 2218–2233.[Abstract/Free Full Text]

Jiang Q-X, Thrower EC, Chester DW, Ehrlich BE & Sigworth FJ 2002 Three-dimensional structure of the type 1 inositol 1,4,5-trisphosphate receptor at 24 A resolution. EMBO Journal 21 3575–3581.[CrossRef][Web of Science][Medline]

Joly M, Kazlauskas A, Fay FS & Corvera S 1994 Disruption of PDGF receptor trafficking by mutation of its PI-3 kinase binding sites. Science 263 684–687.[Abstract/Free Full Text]

Katzmann DJ, Odorozzi G & Emr SD 2002 Receptor downregulation and multivesicular-body sorting. Nature Reviews. Molecular Cell Biology 3 893–905.[CrossRef][Web of Science][Medline]

Kiselyov K, Xu X, Mozhayeva G, Kuo T, Pessah I, Migniery G, Zhu X, Birnbaumer L & Muallem S 1998 Functional interaction between InsP3 receptors and store-operated Htrp3 channels. Nature 396 478–482.[CrossRef][Medline]

Koreh K & Monaco ME 1986 The relationship of hormone-sensitive and hormone-insensitive phosphatidylinositol to phosphatidylinositol 4,5-bisphosphate in the WRK-1 cell. Journal of Biological Chemistry 261 88–91.[Abstract/Free Full Text]

Krapivinsky G, Gordon EA, Wickman K, Velimirovic B, Krapivinsky L & Clapham DE 1995 The G-protein-gated atrial K+ channel IKACh is a heteromultimer of two inwardly rectifying K(+)-channel proteins. Nature 374 135–141.[CrossRef][Medline]

Krylova IN, Sablin EP, Moore J, Xu RX, Waitt GM, MacKay JA, Juzumiene D, Bynum JM, Madauss K, Montana V et al. 2005 Structural analyses reveal phosphatidylinositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120 343–355.[CrossRef][Web of Science][Medline]

Lagace TA, Byers DM, Cook HW & Ridgway ND 1997 Altered regulation of cholesterol and cholesteryl ester synthesis in Chinese-hamster ovary cells overexpressing the oxysterol-binding protein is dependent on the pleckstrin homology domain. Biochemical Journal 326 205–213.[Medline]

Lee A, Frank DW, Marks MS & Lemmon MA 1999 Dominant-negative inhibition of receptor-mediated endocytosis by a dynamin-1 mutant with a defective pleckstrin homology domain. Current Biology 9 261–264.[CrossRef][Web of Science][Medline]

Lee S-J, Xu H, Kang L-W, Amzel LM & Montell C 2003 Light adaptation through phosphoinositide-regulated translocation of Drosophila visual arrestin. Neuron 39 121–132.[CrossRef][Web of Science][Medline]

Lefkowitz RJ 1993 G protein-coupled receptor kinases. Cell 74 409–412.[CrossRef][Web of Science][Medline]

Lehto M & Olkkonen VM 2003 The OSBP-related proteins: a novel protein family involved in vesicle transport, cellular lipid metabolism, and cell signalling. Biochimica Biophysica Acta 1631 1–11.[Medline]

Lemmon MA & Ferguson KM 2000 Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochemical Journal 350 1–18.[CrossRef][Web of Science][Medline]

Leopoldt D, Hanck T, Exner T, Maier U, Wetzker R & Nurnberg B 1998 Gß{gamma} stimulates phosphoinositide 3-kinase-gamma by direct interaction with two domains of the catalytic p110 subunit. Journal of Biological Chemistry 273 7024–7029.[Abstract/Free Full Text]

Li Y, Choi M, Cavey G, Daugherty J, Suino K, Kovach A, Bingham NC, Kliewer SA & Xu EH 2005 Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Molecular Cell 17 491–502.[CrossRef][Web of Science][Medline]

Lintschinger B, Balzer-Geldsetzer M, Baskaran T, Graier WF, Romanin C, Zhu MX & Groschner K 2000 Coassembly of Trp1 and Trp3 proteins generates diacylglycerol- and Ca2+-sensitive cation channels. Journal of Biological Chemistry 275 27799–27805.[Abstract/Free Full Text]

Liou J, Kim ML, Heo WD, Jones JT, Myers JW, Ferrell JE Jr & Meyer T 2005 STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Current Biology 15 1235–1241.[CrossRef][Web of Science][Medline]

Litvak V, Dahan N, Ramachandran S, Sabanay H & Lev S 2005 Maintenance of the diacylglycerol level in the Golgi apparatus by the Nir2 protein is critical for Golgi secretory function. Nature Cell Biology 7 225–234.[CrossRef][Web of Science][Medline]

Liu B, Zhang C & Qin F 2005 Functional recovery from desensitization of vanilloid receptor TRPV1 requires resynthesis of phosphatidylinositol 4,5-bisphosphate. Journal of Neuroscience 25 4835–4843.[Abstract/Free Full Text]

Liu X, Singh BB & Ambudkar IS 2003 TRPC1 is required for functional store-operated Ca2+ channels. Role of acidic amino acid residues in the S5–S6 region. Journal of Biological Chemistry 278 11337–11343.[Abstract/Free Full Text]

Lopes CM, Rohacs T, Czirjak G, Balla T, Enyedi P & Logothetis DE 2005 PIP2 hydrolysis underlies agonist-induced inhibition and regulates voltage gating of two-pore domain K+ channels. Journal of Physiology (Lond) 564 117–129.

Loyet KM, Kowalchyk JA, Chaudhary A, Chen J, Prestwitch GD & Martin TF 1998 Specific binding of phosphatidylinositol 4,5-bisphosphate to calcium-dependent activator protein for secretion (CAPS), a potential phosphoinositide effector protein for regulated exocytosis. Journal of Biological Chemistry 273 8337–8343.[Abstract/Free Full Text]

Luo J, Field SJ, Lee JY, Engelman JA & Cantley LC 2005 The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. Journal of Cell Biology 170 455–464.[Abstract/Free Full Text]

Luttrell LM & Lefkowitz RJ 2002 The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. Journal of Cell Science 115 455–465.[Abstract/Free Full Text]

Maeda N, Kawasaki T, Nakade S, Yokota N, Taguchi T, Kasai M & Mikoshiba K 1991 Structural and functional characterization of inositol 1,4,5-trisphosphate receptor channel from mouse cerebellum. Journal of Biological Chemistry 266 1109–1116.[Abstract/Free Full Text]

Majerus PW, Kisseleva MV & Norris FA 1999 The role of phosphatases in inositol signaling reactions. Journal of Biological Chemistry 274 10669–10672.[Free Full Text]

Mak DO & Foskett JK 1994 Single-channel inositol 1,4,5-trisphosphate receptor currents revealed by patch clamp of isolated Xenopus oocyte nuclei. Journal of Biological Chemistry 269 29375–29378.[Abstract/Free Full Text]

Manzoli L, Martelli AM, Billi AM, Faenza I, Fiume R & Cocco L 2005 Nuclear phospholipase C: involvement in signal transduction. Progress in Lipid Research 44 185–206.[CrossRef][Web of Science][Medline]

Marchese A & Benovic JL 2001 Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. Journal of Biological Chemistry 276 45509–45512.[Abstract/Free Full Text]

Martin TF 2003 Tuning exocytosis for speed: fast and slow modes. Biochimica Biophysica Acta 1641 157–165.[Medline]

Martin TFJ, Loyet KM, Barry VA & Kowalchik JA 1997 The role of PtdIns(4,5)P2 in exocytotic membrane fusion. Biochemical Society Transactions 25 1137–1141.[Web of Science][Medline]

McPherson PS, Garcia EP, Slepnev VI, David C, Zhang X, Grabs D, Sossin WS, Bauerfeind R, Nemoto Y & De Camilli P 1996 A presynaptic inositol-5-phosphatase. Nature 379 353–357.[CrossRef][Medline]

Meunier FA, Osborne SL, Hammond GR, Cooke FT, Parker PJ, Domin J & Schiavo G 2005 Phosphatidylinositol 3-kinase C2{alpha} is essential for ATP-dependent priming of neurosecretory granule exocytosis. Molecular Biology of the Cell 16 4841–4851.[Abstract/Free Full Text]

Michell RH 1982 Is phosphatidylinositol really out of the calcium gate? Nature 296 492–493.[CrossRef][Medline]

Mignery GA & Sudhof TC 1990 The ligand binding site and transduction mechanism in the inositol-1,4,5-triphosphate receptor. EMBO Journal 9 3893–3898.[Web of Science][Medline]

Mignery GA, Sudhof TC, Takei K & De Camilli P 1989 Putative receptor for inositol 1,4,5-trisphosphate similar to ryanodine receptor. Nature 342 192–195.[CrossRef][Medline]

Mikoshiba K 1993 Inositol 1,4,5-trisphosphate receptor. Trends in Pharmacological Sciences 14 86–89.[CrossRef][Medline]

Mikoshiba K 1997 The InsP3 receptor and intracellular signaling. Current Opinion in Neurobiology 7 339–345.[CrossRef][Web of Science][Medline]

Milosevic I, Sorensen JB, Lang T, Krauss M, Nagy G, Haucke V, Jahn R & Neher E 2005 Plasmalemmal phosphatidylinositol-4,5-bisphosphate level regulates the releasable vesicle pool size in chromaffin cells. Journal of Neuroscience 25 2557–2565.[Abstract/Free Full Text]

Mora A, Komander D, Van Aalten DM & Alessi DR 2004 PDK1, the master regulator of AGC kinase signal transduction. Seminars in Cellular and Developmental Biology 15 161–170.

Mori Y, Wakamori M, Miyakawa T, Hermosura M, Hara Y, Nishida M, Hirose K, Mizushima A, Kurosaki M, Mori E et al. 2002 Transient receptor potential 1 regulates capacitative Ca2+ entry and Ca2+ release from endoplasmic reticulum in B lymphocytes. Journal of Experimental Medicine 195 673–681.[Abstract/Free Full Text]

Naga Prasad SV, Laporte SA, Chamberlain D, Caron MG, Barak L & Rockman HL 2002 Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex. Journal of Cell Biology 158 563–575.[Abstract/Free Full Text]

Naga Prasad SV, Jayatilleke A, Madamanchi A & Rockman HA 2005 Protein kinase activity of phosphoinositide 3-kinase regulates beta-adrenergic receptor endocytosis. Nature Cell Biology 7 785–796.[CrossRef][Web of Science][Medline]

Nakanishi S, Catt KJ & Balla T 1995 A wortmannin-sensitive phosphatidylinositol 4-kinase that regulates hormone-sensitive pools of inositolphospholipids. PNAS 92 5317–5321.[Abstract/Free Full Text]

Nishizuka Y 1988 The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 34 661–665.

Oda H, Murayama T & Nomura Y 1997 Inhibition of protein kinase C-dependent noradrenaline release by wortmannin in PC12 cells. Archives in Biochemistry and Biophysics 337 96–102.[CrossRef][Web of Science][Medline]

Odom AR, Stahlberg A, Wente SR & York JD 2000 A role for nuclear inositol 1,4,5-trisphosphate kinase in transcriptional control. Science 287 2026–2029.[Abstract/Free Full Text]

Odorozzi G, Babst M & Emr SD 1998 Fab1p PtdIns(3)P 5-kinase function essential for protein sorting in the multivesicular body. Cell 95 847–858.[CrossRef][Web of Science][Medline]

Okamoto M & Sudhof TC 1997 Mints, Munc18-interacting proteins in synaptic vesicle exocytosis. Journal of Biological Chemistry 272 31459–31464.[Abstract/Free Full Text]

Olkkonen VM & Lehto M 2004 Oxysterols and oxysterol binding proteins: role in lipid metabolism and atherosclerosis. Annals of Medicine 36 562–572.[CrossRef][Web of Science][Medline]

Olsen HL, Hoy M, Zhang W, Bertorello AM, Bokvist K, Capito K, Efanov AM, Meister B, Thams P, Yang SN et al. 2003 Phosphatidylinositol 4-kinase serves as a metabolic sensor and regulates priming of secretory granules in pancreatic beta cells. PNAS 100 5187–5192.[Abstract/Free Full Text]

Otsu M, Hiles I, Gout I, Fry MJ, Ruiz-Larrea F, Panayotou G, Thompson A, Dhand R, Hsuan JJ et al. 1991 Characterization of two 85 kDa proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase. Cell 65 91–104.[CrossRef][Web of Science][Medline]

Owen DJ, Collins BM & Evans PR 2004 Adaptors for clathrin coats: structure and function. Annual Review of Cell and Developmental Biology 20 153–191.[CrossRef][Web of Science][Medline]

Pacher P & Hajnoczky G 2001 Propagation of the apoptotic signal by mitochondrial waves. EMBO Journal 20 4107–4121.[CrossRef][Web of Science][Medline]

Padron D, Wang YJ, Yamamoto M, Yin H & Roth MG 2003 Phosphatidylinositol phosphate 5-kinase Ibeta recruits AP-2 to the plasma membrane and regulates rates of constitutive endocytosis. Journal of Cell Biology 162 693–701.[Abstract/Free Full Text]

Parekh AB & Putney JW Jr 2005 Store-operated calcium channels. Physiological Reviews 85 757–810.[Abstract/Free Full Text]

Parrish WR, Stefan CJ & Emr SD 2004 Essential role for the myotubularin-related phosphatase Ymr1p and the synaptojanin-like phosphatases Sjl2p and Sjl3p in regulation of phosphatidylinositol 3-phosphate in yeast. Molecular Biology of the Cell 15 3567–3579.[Abstract/Free Full Text]

Patel S, Joseph SK & Thomas AP 1999 Molecular properties of inositol 1,4,5-trisphosphate receptors. Cell Calcium 25 247–264.[CrossRef][Web of Science][Medline]

Patterson RL, van Rossum DB, Ford DL, Hurt KJ, Bae SS, Suh PG, Kurosaki T, Snyder SH & Gill DL 2002 Phospholipase C-gamma is required for agonist-induced Ca2+ entry. Cell 111 529–541.[CrossRef][Web of Science][Medline]

Payrastre B, Nievers M, Boonstra J, Breton M, Verkleij AJ & VanBergen en Henegouwen PMP 1992 A differential location of phosphoinositide kinases, diacylglycerol kinase, and phospholipase C in the nuclear matrix. Journal of Biological Chemistry 267 5078–5084.[Abstract/Free Full Text]

Pendaries C, Tronchere H, Plantavid M & Payrastre B 2003 Phosphoinositide signaling disorders in human diseases. FEBS Letters 546 25–31.[CrossRef][Web of Science][Medline]

Perry RJ & Ridgway ND 2005 Molecular mechanisms and regulation of ceramide transport. Biochimica Biophysica Acta 1734 220–234.[Medline]

Pitcher JA, Freedman NJ & Lefkowitz RJ 1998 G protein-coupled receptor kinases. Annual Review of Biochemistry 67 653–692.[CrossRef][Web of Science][Medline]

Pongs O, Lindemeier J, Zhu XR, Theil T, Engelkamp D, Krah-Jentgens I, Lambrecht H-G, Koch KW, Schwemer J, Rivosecchi R et al. 1993 Frequenin, a novel calcium-binding protein that modulates synaptic efficacy in the Drosophila nervous system. Neuron 11 15–28.[CrossRef][Web of Science][Medline]

Putney JW Jr 1986 A model for receptor-regulated calcium entry. Cell Calcium 7 1–12.[CrossRef][Web of Science][Medline]

Putney JW Jr 2004 The enigmatic TRPCs: multifunctional cation channels. Trends in Cell Biology 14 282–286.[CrossRef][Web of Science][Medline]

Rameh LE, Tolias KF, Duckworth BC & Cantley LC 1997 A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate. Nature 390 192–196.[CrossRef][Medline]

Rao K, Paik WY, Zheng L, Jobin RM, Tomic M, Jiang H, Nakanishi S & Stojilkovic SS 1997 Wortmannin-sensitive and -insensitive steps in calcium-controlled exocytosis in pituitary gonadotrophs: evidence that myosin light chain kinase mediates calcium-dependent and wortmannin-sensitive gonadotropin secretion. Endocrinology 138 1440–1449.[Abstract/Free Full Text]

Rebecchi MJ & Pentyala SN 2000 Structure, function, and control of phosphoinositide-specific phospholipase C. Physiological Reviews 80 1291–1335.[Abstract/Free Full Text]

Revankar CM, Cimino DF, Sklar LA, Arterburn JB & Prossnitz ER 2005 A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307 1625–1630.[Abstract/Free Full Text]

Rhee SG 2001 Regulation of phosphoinositide-specific phospholipase C. Annual Review of Biochemistry 70 281–312.[CrossRef][Web of Science][Medline]

Ridgway ND, Dawson PA, Ho YK, Brown MS & Goldstein JL 1992 Translocation of oxysterol binding protein to Golgi apparatus triggered by ligand binding. Journal of Cell Biology 116 307–319.[Abstract/Free Full Text]

Rizzuto R, Brini M, Murgia M & Pozzan T 1993 Microdomains with high Ca2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria. Science 262 744–747.[Abstract/Free Full Text]

Rohacs T, Lopes CM, Michailidis I & Logothetis DE 2005 PI(4,5)P2 regulates the activation and desensitization of TRPM8 channels through the TRP domain. Nature Neuroscience 8 626–634.[CrossRef][Web of Science][Medline]

Roos J, DiGregorio PJ, Yeromin AV, Ohlsen K, Lioudyno M, Zhang S, Safrina O, Kozak JA, Wagner SL, Cahalan MD et al. 2005 STIM1, an essential and conserved component of store-operated Ca2+ channel function. Journal of Cell Biology 169 435–445.[Abstract/Free Full Text]

Routt SM & Bankaitis VA 2004 Biological functions of phosphatidylinositol transfer proteins. Biochemistry and Cell Biology 82 254–262.[CrossRef][Web of Science][Medline]

Runnels LW, Yue LX & Clapham DE 2002 The TRPM7 channel is inactivated by PIP2 hydrolysis. Nature Cell Biology 15 370–378.

Saiardi A, Resnick AC, Snowman AM, Wendland B & Snyder SH 2005 Inositol pyrophosphates regulate cell death and telomere length through phosphoinositide 3-kinase-related protein kinases. PNAS 102 1911–1914.[Abstract/Free Full Text]

Saito K, Tolias KF, Saci A, Koon HB, Humphries LA, Scharenberg A, Rawlings DJ, Kinet JP & Carpenter CL 2003 BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity. Immunity 19 669–678.[CrossRef][Web of Science][Medline]

Santagata S, Boggon TJ, Baird CL, Gomez CA, Zhao J, Shan WS, Myszka DG & Shapiro L 2001 G-protein signaling through tubby proteins. Science 292 2041–2050.[Abstract/Free Full Text]

Sato C, Hamada K, Ogura T, Miyazawa A, Iwasaki K, Hiroaki Y, Tani K, Terauchi A, Fujiyoshi Y & Mikoshiba K 2004 Inositol 1,4,5-trisphosphate receptor contains multiple cavities and L-shaped ligand-binding domains. Journal of Molecular Biology 336 155–164.[CrossRef][Web of Science][Medline]

Schiavo G, Gu QM, Prestwich GD, Sollner TH & Rothmann JE 1996 Calcium-dependent switching of the specificity of phosphoinositide binding to synaptotagmin. PNAS 93 13327–13332.[Abstract/Free Full Text]

Seachrist JL, Anborgh PH & Ferguson SS 2000 Beta 2-adrenergic receptor internalization, endosomal sorting, and plasma membrane recycling are regulated by Rab GTPases. Journal of Biological Chemistry 275 27221–27228.[Abstract/Free Full Text]

Shears SB 1998 The versatility of inositol phosphates as cellular signals. Biochimica Biophysica Acta 1436 49–67.[Medline]

Shears SB 2004 How versatile are inositol phosphate kinases? Biochemical Journal 377 265–280.[CrossRef][Web of Science][Medline]

Shenoy SK, McDonald PH, Kohout TA & Lefkowitz RJ 2001 Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 294 1307–1313.[Abstract/Free Full Text]

Shin HW, Hayashi M, Christoforidis S, Lacas-Gervais S, Hoepfner S, Wenk MR, Modregger J, Uttenweiler-Joseph S, Wilm M, Nystuen A et al. 2005 An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway. Journal of Cell Biology 170 607–618.[Abstract/Free Full Text]

Shisheva A, Sbrissa D & Ikonomov O 1999 Cloning, characterization, and expression of a novel Zn2+-binding FYVE finger-containing phosphoinositide kinase in insulin-sensitive cells. Molecular and Cellular Biology 19 623–634.[Abstract/Free Full Text]

Shpetner H, Joly M, Hartley D & Corvera S 1996 Potential sites of PI-3 kinase function in the endocytic pathway revealed by the PI-3 kinase inhibitor, wortmannin. Journal of Cell Biology 132 595–605.[Abstract/Free Full Text]

Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW & Liao JK 2000 Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407 538–541.[CrossRef][Medline]

Sorensen SD, Linseman DA, McEwen EL, Heacock AM & Fisher SK 1998 A role for a wortmannin-sensitive phosphatidylinositol-4-kinase in the endocytosis of muscarinic cholinergic receptors. Molecular Pharmacology 53 827–836.[Abstract/Free Full Text]

Stephens LR, Smrcka AV, Cooke FT, Jackson TR, Sternweis PC & Hawkins PT 1994 A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein beta-gamma subunits. Cell 77 83–93.[CrossRef][Web of Science][Medline]

Stephens LR, Eguinoa A, Erdjument-Bromage H, Lui M, Cooke F, Coadwell J, Smrcka AS, Thelen M, Cadwallader K, Tempst P et al. 1997 The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell 89 105–114.[CrossRef][Web of Science][Medline]

Storey MK, Byers DM, Cook HW & Ridgway ND 1998 Cholesterol regulates oxysterol binding protein (OSBP) phosphorylation and Golgi localization in Chinese hamster ovary cells: correlation with stimulation of sphingomyelin synthesis by 25-hydroxycholesterol. Biochemical Journal 336 247–256.[Medline]

Straub SG & Sharp GW 1996 A wortmannin-sensitive signal transduction pathway is involved in the stimulation of insulin release by vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide. Journal of Biological Chemistry 271 1660–1668.[Abstract/Free Full Text]

Strubing C, Krapivinsky G, Krapivinsky L & Clapham DE 2001 TRPC1 and TRPC5 form a novel cation channel in mammalian brain. Neuron 29 645–655.[CrossRef][Web of Science][Medline]

Suh BC & Hille B 2002 Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis. Neuron 35 507–520.[CrossRef][Web of Science][Medline]

Suire S, Coadwell J, Ferguson GJ, Davidson K, Hawkins P & Stephens L 2005 p84, a new Gß{gamma}-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110{gamma}. Cu rrent Biology 15 566–570.

Taylor CW & Laude AJ 2002 IP3 receptors and their regulation by calmodulin and cytosolic Ca2+. Cell Calcium 32 321–334.[CrossRef][Web of Science][Medline]

Taylor GS & Dixon JE 2003 PTEN and myotubularins: families of phosphoinositide phosphatases. Methods in Enzymology 366 43–56.[Web of Science][Medline]

Terauchi Y, Tsuji Y, Satoh S, Minoura H, Murakami K, Okuno A, Inukai K, Asano T, Kaburagi Y, Ueki K et al. 1999 Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase. Nature Genetics 21 230–235.[CrossRef][Web of Science][Medline]

Thomas GMH, Cunningham E, Fensome A, Ball A, Totty NF, Truong O, Hsuan JJ & Cockcroft S 1993 An essential role of phosphatidylinositol transfer protein in phospholipase C-mediated inositol lipid signaling. Cell 74 919–928.[CrossRef][Web of Science][Medline]

Trotter PJ, Wu W-I, Pedretti J, Yates R & Voelker DR 1998 A genetic screen for aminophospholipid transport mutants identifies the phosphatidylinositol 4-kinase, Stt4p, as an essential component in phosphatidylserine metabolism. Journal of Biological Chemistry 273 13189–13196.[Abstract/Free Full Text]

Tucker WC & Chapman ER 2002 Role of synaptotagmin in Ca2+-triggered exocytosis. Biochemical Journal 366 1–13.[Web of Science][Medline]

van Dam EM, Ten Broeke T, Jansen K, Spijkers P & Stoorvogel W 2002 Endocytosed transferrin receptors recycle via distinct dynamin and phosphatidylinositol 3-kinase-dependent pathways. Journal of Biological Chemistry 277 48876–48883.[Abstract/Free Full Text]

van Rossum DB, Patterson RL, Sharma S, Barrow RK, Kornberg M, Gill DL & Snyder SH 2005 Phospholipase Cgamma1 controls surface expression of TRPC3 through an intermolecular PH domain. Nature 434 99–104.[CrossRef][Medline]

Verbsky JW, Chang SC, Wilson MP, Mochizuki Y & Majerus PW 2005 The pathway for the production of inositol hexakisphosphate in human cells. Journal of Biological Chemistry 280 1911–1920.[Abstract/Free Full Text]

Viard P, Butcher AJ, Halet G, Davies A, Nurnberg B, Heblich F & Dolphin AC 2004 PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane. Nature Neuroscience 7 939–946.[CrossRef][Web of Science][Medline]

Vieira OV, Verkade P & Simons K 2005 FAPP2 is involved in the transport of apical cargo in polarized MDCK cells. Journal of Cell Biology 170 521–526.[Abstract/Free Full Text]

Vihtelic TS, Goeb M, Milligan S, O’Tousa JE & Hyde DR 1993 Localization of Drosophila retinal degeneration B, a membrane-associated phosphatidylinositol transfer protein. Journal of Cell Biology 122 1013–1022.[Abstract/Free Full Text]

Voelker DR 2005 Bridging gaps in phospholipid transport. Trends in Biochemical Sciences 30 396–404.[CrossRef][Web of Science][Medline]

Walent JH, Porter BW & Martin TF 1992 A novel 145 kd brain cytosolic protein reconstitutes Ca(2+)-regulated secretion in permeable neuroendocrine cells. Cell 70 765–775.[CrossRef][Web of Science][Medline]

Wang YJ, Li WH, Wang J, Xu K, Dong P, Luo X & Yin HL 2004 Critical role of PIP5KI{gamma} 87 in InsP3-mediated Ca(2+) signaling. Journal of Cell Biology 167 1005–1010.[Abstract/Free Full Text]

Waselle L, Gerona RR, Vitale N, Martih TF, Bader MF & Regazzi R 2005 Role of phosphoinositide signaling in the control of insulin exocytosis. Molecular Endocrinology 19 3097–3106.[Abstract/Free Full Text]

Watt SA, Kular G, Fleming IN, Downes CP & Lucocq JM 2002 Subcellular localization of phosphatidylinositol 4,5-bisphosphate using the pleckstrin homology domain of phospholipase C delta1. Biochemical Journal 363 657–666.[CrossRef][Web of Science][Medline]

Wei YJ, Sun HQ, Yamamoto M, Wlodarski P, Kunii K, Martinez M, Barylko B, Albanesi JP & Yin HL 2002 Type II phosphatidylinositol 4-kinase beta is a cytosolic and peripheral membrane protein that is recruited to the plasma membrane and activated by Rac-GTP. Journal of Biological Chemistry 277 46586–46593.[Abstract/Free Full Text]

Weisz OA, Gibson GA, Leung SM, Roder J & Jeromin A 2000 Overexpression of frequenin, a modulator of phosphatidylinositol 4-kinase, inhibits biosynthetic delivery of an apical protein in polarized madin-darby canine kidney cells. Journal of Biological Chemistry 275 24341–24347.[Abstract/Free Full Text]

Wenk MR & De Camilli P 2004 Protein–lipid interactions and phosphoinositide metabolism in membrane traffic: insights from vesicle recycling in nerve terminals. PNAS 101 8262–8269.[Abstract/Free Full Text]

Wenk MR, Pellegrini L, Klenchin VA, Di Paolo G, Chang S, Daniell L, Arioka M, Martin TF & De Camilli P 2001 PIP kinase Igamma is the major PI(4,5)P2 synthesizing enzyme at the synapse. Neuron 31 79–88.

Wes PD, Chevesich J, Jeromin A, Rosenberg C, Stetten G & Montell C 1995 TRPC1, a human homolog of a Drosophila store-operated channel. PNAS 92 9652–9656.[Abstract/Free Full Text]

Whitters EA, Cleves AE, McGee TP, Skinner HB & Bankaitis VA 1993 SAC1p is an integral membrane protein that influences the cellular requirement for phospholipid transfer protein function and inositol in yeast. Journal of Cell Biology 122 79–94.[Abstract/Free Full Text]

Wiedemann C, Schä fer T & Burger MM 1996 Chromaffin granule-associated phosphatidylinositol 4-kinase activity is required for stimulated secretion. EMBO Journal 15 2094–2101.[Web of Science][Medline]

Wong K, Meyers R & Cantley LC 1997 Subcellular localization of phosphatidylinositol 4-kinase isoforms. Journal of Biological Chemistry 272 13236–13241.[Abstract/Free Full Text]

Xu C, Watras J & Loew LM 2003 Kinetic analysis of receptor-activated phosphoinositide turnover. Journal of Cell Biology 161 779–791.[Abstract/Free Full Text]

Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y, Nonomura Y & Matsuda Y 1993 Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. Journal of Biological Chemistry 268 25846–25856.[Abstract/Free Full Text]

York SJ, Armbruster BN, Greenwell P, Petes TD & York JD 2005 Inositol diphosphate signaling regulates telomere length. Journal of Biological Chemistry 280 4264–4269.[Abstract/Free Full Text]

Zhang H, He C, Yan X, Mirshaki T & Logothetis DE 1999 Activation of inwardly rectifying K+ channels by distinct PtdIns(4,5)P2 interactions. Nature Cell Biology 1 183–188.[CrossRef][Web of Science][Medline]

Zhang H, Craciun LC, Mirshahi T, Rohacs T, Lopes CM, Jin T & Logothetis DE 2003 PIP(2) activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents. Neuron 37 963–975.[CrossRef][Web of Science][Medline]

Zhang J, Barak LS, Anborgh PH, Laporte SA, Caron MG & Ferguson SS 1999 Cellular trafficking of G protein-coupled receptor/beta-arrestin endocytic complexes. Journal of Biological Chemistry 274 10999–11006.[Abstract/Free Full Text]

Zhu X, Jiang M, Peyton M, Boulay G, Hurst R, Stefani E & Birnbaumer L 1996 Trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry. Cell 85 661–671.[CrossRef][Web of Science][Medline]

Received in final form 19 December 2005
Accepted 22 December 2005



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
O. C. Ikonomov, D. Sbrissa, H. Fenner, and A. Shisheva
PIKfyve-ArPIKfyve-Sac3 Core Complex: CONTACT SITES AND THEIR CONSEQUENCE FOR Sac3 PHOSPHATASE ACTIVITY AND ENDOCYTIC MEMBRANE HOMEOSTASIS
J. Biol. Chem., December 18, 2009; 284(51): 35794 - 35806.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
V. Meyer, M. Arentshorst, S. J. Flitter, B. M. Nitsche, M. J. Kwon, C. G. Reynaga-Pena, S. Bartnicki-Garcia, C. A. M. J. J. van den Hondel, and A. F. J. Ram
Reconstruction of Signaling Networks Regulating Fungal Morphogenesis by Transcriptomics
Eukaryot. Cell, November 1, 2009; 8(11): 1677 - 1691.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
G. R.V. Hammond, Y. Sim, L. Lagnado, and R. F. Irvine
Reversible binding and rapid diffusion of proteins in complex with inositol lipids serves to coordinate free movement with spatial information
J. Cell Biol., January 26, 2009; 184(2): 297 - 308.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
T. Ischebeck, I. Stenzel, and I. Heilmann
Type B Phosphatidylinositol-4-Phosphate 5-Kinases Mediate Arabidopsis and Nicotiana tabacum Pollen Tube Growth by Regulating Apical Pectin Secretion
PLANT CELL, December 1, 2008; 20(12): 3312 - 3330.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
I. Stenzel, T. Ischebeck, S. Konig, A. Holubowska, M. Sporysz, B. Hause, and I. Heilmann
The Type B Phosphatidylinositol-4-Phosphate 5-Kinase 3 Is Essential for Root Hair Formation in Arabidopsis thaliana
PLANT CELL, January 1, 2008; 20(1): 124 - 141.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Sbrissa, O. C. Ikonomov, Z. Fu, T. Ijuin, J. Gruenberg, T. Takenawa, and A. Shisheva
Core Protein Machinery for Mammalian Phosphatidylinositol 3,5-Bisphosphate Synthesis and Turnover That Regulates the Progression of Endosomal Transport: NOVEL SAC PHOSPHATASE JOINS THE ArPIKfyve-PIKfyve COMPLEX
J. Biol. Chem., August 17, 2007; 282(33): 23878 - 23891.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
B. B. Yaroslavskiy, A. C. Sharrow, A. Wells, L. J. Robinson, and H. C. Blair
Necessity of inositol (1,4,5)-trisphosphate receptor 1 and {micro}-calpain in NO-induced osteoclast motility
J. Cell Sci., August 15, 2007; 120(16): 2884 - 2894.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Konig, A. Mosblech, and I. Heilmann
Stress-inducible and constitutive phosphoinositide pools have distinctive fatty acid patterns in Arabidopsis thaliana
FASEB J, July 1, 2007; 21(9): 1958 - 1967.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. Urbanczyk, O. Chernysh, M. Condrescu, and J. P. Reeves
Sodium-calcium exchange does not require allosteric calcium activation at high cytosolic sodium concentrations
J. Physiol., September 15, 2006; 575(3): 693 - 705.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balla, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balla, T


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS